ID   BRD4_HUMAN              Reviewed;        1362 AA.
AC   O60885; O60433; Q4G0X8; Q86YS8; Q96PD3;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   31-JAN-2002, sequence version 2.
DT   12-OCT-2022, entry version 204.
DE   RecName: Full=Bromodomain-containing protein 4;
DE   AltName: Full=Protein HUNK1;
GN   Name=BRD4; Synonyms=HUNK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), DISEASE, AND CHROMOSOMAL
RP   TRANSLOCATION WITH NUT.
RX   PubMed=11733348; DOI=10.1016/s0002-9440(10)63049-0;
RA   French C.A., Miyoshi I., Aster J.C., Kubonishi I., Kroll T.G., Dal Cin P.,
RA   Vargas S.O., Perez-Atayde A.R., Fletcher J.A.;
RT   "BRD4 bromodomain gene rearrangement in aggressive carcinoma with
RT   translocation t(15;19).";
RL   Am. J. Pathol. 159:1987-1992(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM C).
RC   TISSUE=Placenta;
RA   Weber B.;
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-719, DISEASE, CHROMOSOMAL TRANSLOCATION
RP   WITH NUT, AND TISSUE SPECIFICITY.
RC   TISSUE=Carcinoma;
RX   PubMed=12543779;
RA   French C.A., Miyoshi I., Kubonishi I., Grier H.E., Perez-Atayde A.R.,
RA   Fletcher J.A.;
RT   "BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.";
RL   Cancer Res. 63:304-307(2003).
RN   [7]
RP   FUNCTION, INTERACTION WITH CDK9 AND CCNT1, IDENTIFICATION IN THE P-TEFB
RP   COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=16109376; DOI=10.1016/j.molcel.2005.06.027;
RA   Jang M.K., Mochizuki K., Zhou M., Jeong H.S., Brady J.N., Ozato K.;
RT   "The bromodomain protein Brd4 is a positive regulatory component of P-TEFb
RT   and stimulates RNA polymerase II-dependent transcription.";
RL   Mol. Cell 19:523-534(2005).
RN   [8]
RP   FUNCTION, INTERACTION WITH CDK9 AND CCNT1, AND IDENTIFICATION IN THE P-TEFB
RP   COMPLEX.
RX   PubMed=16109377; DOI=10.1016/j.molcel.2005.06.029;
RA   Yang Z., Yik J.H., Chen R., He N., Jang M.K., Ozato K., Zhou Q.;
RT   "Recruitment of P-TEFb for stimulation of transcriptional elongation by the
RT   bromodomain protein Brd4.";
RL   Mol. Cell 19:535-545(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1117, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   INTERACTION WITH KSHV PROTEIN LANA (MICROBIAL INFECTION).
RX   PubMed=16940503; DOI=10.1128/jvi.00502-06;
RA   You J., Srinivasan V., Denis G.V., Harrington W.J. Jr., Ballestas M.E.,
RA   Kaye K.M., Howley P.M.;
RT   "Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen
RT   interacts with bromodomain protein Brd4 on host mitotic chromosomes.";
RL   J. Virol. 80:8909-8919(2006).
RN   [11]
RP   INTERACTION WITH BOVINE PAPILLOMAVIRUS TYPE 1 REGULATORY PROTEIN E2.
RX   PubMed=17189189; DOI=10.1016/j.molcel.2006.11.005;
RA   Parish J.L., Bean A.M., Park R.B., Androphy E.J.;
RT   "ChlR1 is required for loading papillomavirus E2 onto mitotic chromosomes
RT   and viral genome maintenance.";
RL   Mol. Cell 24:867-876(2006).
RN   [12]
RP   INTERACTION WITH EPSTEIN-BARR VIRUS PROTEIN EBNA1.
RX   PubMed=18922874; DOI=10.1128/jvi.01680-08;
RA   Lin A., Wang S., Nguyen T., Shire K., Frappier L.;
RT   "The EBNA1 protein of Epstein-Barr virus functionally interacts with
RT   Brd4.";
RL   J. Virol. 82:12009-12019(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-470, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   FUNCTION.
RX   PubMed=19596240; DOI=10.1016/j.cell.2009.05.047;
RA   Hargreaves D.C., Horng T., Medzhitov R.;
RT   "Control of inducible gene expression by signal-dependent transcriptional
RT   elongation.";
RL   Cell 138:129-145(2009).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH RELA.
RX   PubMed=19103749; DOI=10.1128/mcb.01365-08;
RA   Huang B., Yang X.D., Zhou M.M., Ozato K., Chen L.F.;
RT   "Brd4 coactivates transcriptional activation of NF-kappaB via specific
RT   binding to acetylated RelA.";
RL   Mol. Cell. Biol. 29:1375-1387(2009).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1111, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-601 AND SER-1117, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   INTERACTION WITH NSD3; JMJD6; CHD4; BICRA AND ATAD5.
RX   PubMed=21555454; DOI=10.1128/mcb.01341-10;
RA   Rahman S., Sowa M.E., Ottinger M., Smith J.A., Shi Y., Harper J.W.,
RA   Howley P.M.;
RT   "The Brd4 extraterminal domain confers transcription activation independent
RT   of pTEFb by recruiting multiple proteins, including NSD3.";
RL   Mol. Cell. Biol. 31:2641-2652(2011).
RN   [21]
RP   SUBCELLULAR LOCATION.
RX   PubMed=21890894; DOI=10.1093/nar/gkr698;
RA   Ai N., Hu X., Ding F., Yu B., Wang H., Lu X., Zhang K., Li Y., Han A.,
RA   Lin W., Liu R., Chen R.;
RT   "Signal-induced Brd4 release from chromatin is essential for its role
RT   transition from chromatin targeting to transcriptional regulation.";
RL   Nucleic Acids Res. 39:9592-9604(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-601 AND SER-1117, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [23]
RP   FUNCTION.
RX   PubMed=22334664; DOI=10.1074/jbc.m111.323493;
RA   Wang R., Li Q., Helfer C.M., Jiao J., You J.;
RT   "Bromodomain protein Brd4 associated with acetylated chromatin is important
RT   for maintenance of higher-order chromatin structure.";
RL   J. Biol. Chem. 287:10738-10752(2012).
RN   [24]
RP   FUNCTION.
RX   PubMed=23086925; DOI=10.1074/jbc.m112.413047;
RA   Zhang W., Prakash C., Sum C., Gong Y., Li Y., Kwok J.J., Thiessen N.,
RA   Pettersson S., Jones S.J., Knapp S., Yang H., Chin K.C.;
RT   "Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine
RT   2 phosphorylation in human CD4+ T cells.";
RL   J. Biol. Chem. 287:43137-43155(2012).
RN   [25]
RP   FUNCTION.
RX   PubMed=22509028; DOI=10.1073/pnas.1120422109;
RA   Devaiah B.N., Lewis B.A., Cherman N., Hewitt M.C., Albrecht B.K.,
RA   Robey P.G., Ozato K., Sims R.J. III, Singer D.S.;
RT   "BRD4 is an atypical kinase that phosphorylates serine2 of the RNA
RT   polymerase II carboxy-terminal domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:6927-6932(2012).
RN   [26]
RP   FUNCTION, AND INTERACTION WITH JMJD6; CDK9 AND CCNT1.
RX   PubMed=24360279; DOI=10.1016/j.cell.2013.10.056;
RA   Liu W., Ma Q., Wong K., Li W., Ohgi K., Zhang J., Aggarwal A.,
RA   Rosenfeld M.G.;
RT   "Brd4 and JMJD6-associated anti-pause enhancers in regulation of
RT   transcriptional pause release.";
RL   Cell 155:1581-1595(2013).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-601; SER-1126; SER-1201 AND
RP   SER-1204, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [28]
RP   FUNCTION, INTERACTION WITH TP53, PHOSPHORYLATION AT SER-484; SER-488;
RP   SER-492; SER-494; SER-498; SER-499 AND SER-503, AND MUTAGENESIS OF
RP   492-SER--SER-494; 498-SER--THR-500 AND SER-503.
RX   PubMed=23317504; DOI=10.1016/j.molcel.2012.12.006;
RA   Wu S.Y., Lee A.Y., Lai H.T., Zhang H., Chiang C.M.;
RT   "Phospho switch triggers Brd4 chromatin binding and activator recruitment
RT   for gene-specific targeting.";
RL   Mol. Cell 49:843-857(2013).
RN   [29]
RP   FUNCTION.
RX   PubMed=23589332; DOI=10.1128/mcb.01180-12;
RA   Patel M.C., Debrosse M., Smith M., Dey A., Huynh W., Sarai N.,
RA   Heightman T.D., Tamura T., Ozato K.;
RT   "BRD4 coordinates recruitment of pause release factor P-TEFb and the
RT   pausing complex NELF/DSIF to regulate transcription elongation of
RT   interferon-stimulated genes.";
RL   Mol. Cell. Biol. 33:2497-2507(2013).
RN   [30]
RP   FUNCTION (ISOFORM B), SUBCELLULAR LOCATION (ISOFORM B), INTERACTION WITH
RP   NCAPD3 AND SMC2, AND MUTAGENESIS OF ASN-140.
RX   PubMed=23728299; DOI=10.1038/nature12147;
RA   Floyd S.R., Pacold M.E., Huang Q., Clarke S.M., Lam F.C., Cannell I.G.,
RA   Bryson B.D., Rameseder J., Lee M.J., Blake E.J., Fydrych A., Ho R.,
RA   Greenberger B.A., Chen G.C., Maffa A., Del Rosario A.M., Root D.E.,
RA   Carpenter A.E., Hahn W.C., Sabatini D.M., Chen C.C., White F.M.,
RA   Bradner J.E., Yaffe M.B.;
RT   "The bromodomain protein Brd4 insulates chromatin from DNA damage
RT   signalling.";
RL   Nature 498:246-250(2013).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-470 AND SER-1117, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [32]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-694 AND LYS-1111, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [33]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1111, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [34]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1111, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [35]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1111, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [36]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-99; LYS-585; LYS-645; LYS-694;
RP   LYS-1050; LYS-1111 AND LYS-1197, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [37]
RP   INTERACTION WITH BICRA.
RX   PubMed=29374058; DOI=10.1074/jbc.ra117.001065;
RA   Alpsoy A., Dykhuizen E.C.;
RT   "Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog
RT   GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes.";
RL   J. Biol. Chem. 293:3892-3903(2018).
RN   [38]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-37; GLY-371; ASN-563; SER-598 AND
RP   HIS-669.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [39]
RP   STRUCTURE BY NMR OF 352-457.
RX   PubMed=18500820; DOI=10.1021/bi8001659;
RA   Liu Y., Wang X., Zhang J., Huang H., Ding B., Wu J., Shi Y.;
RT   "Structural basis and binding properties of the second bromodomain of Brd4
RT   with acetylated histone tails.";
RL   Biochemistry 47:6403-6417(2008).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 44-168 IN COMPLEX WITH JQ1
RP   INHIBITOR, AND SUBCELLULAR LOCATION.
RX   PubMed=20871596; DOI=10.1038/nature09504;
RA   Filippakopoulos P., Qi J., Picaud S., Shen Y., Smith W.B., Fedorov O.,
RA   Morse E.M., Keates T., Hickman T.T., Felletar I., Philpott M., Munro S.,
RA   McKeown M.R., Wang Y., Christie A.L., West N., Cameron M.J., Schwartz B.,
RA   Heightman T.D., La Thangue N., French C.A., Wiest O., Kung A.L., Knapp S.,
RA   Bradner J.E.;
RT   "Selective inhibition of BET bromodomains.";
RL   Nature 468:1067-1073(2010).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 44-168 IN COMPLEX WITH I-BET
RP   INHIBITOR.
RX   PubMed=21068722; DOI=10.1038/nature09589;
RA   Nicodeme E., Jeffrey K.L., Schaefer U., Beinke S., Dewell S., Chung C.W.,
RA   Chandwani R., Marazzi I., Wilson P., Coste H., White J., Kirilovsky J.,
RA   Rice C.M., Lora J.M., Prinjha R.K., Lee K., Tarakhovsky A.;
RT   "Suppression of inflammation by a synthetic histone mimic.";
RL   Nature 468:1119-1123(2010).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 44-168, AND X-RAY CRYSTALLOGRAPHY
RP   (2.3 ANGSTROMS) OF 333-460.
RX   PubMed=21568322; DOI=10.1021/jm200108t;
RA   Chung C.W., Coste H., White J.H., Mirguet O., Wilde J., Gosmini R.L.,
RA   Delves C., Magny S.M., Woodward R., Hughes S.A., Boursier E.V., Flynn H.,
RA   Bouillot A.M., Bamborough P., Brusq J.M., Gellibert F.J., Jones E.J.,
RA   Riou A.M., Homes P., Martin S.L., Uings I.J., Toum J., Clement C.A.,
RA   Boullay A.B., Grimley R.L., Blandel F.M., Prinjha R.K., Lee K.,
RA   Kirilovsky J., Nicodeme E.;
RT   "Discovery and characterization of small molecule inhibitors of the BET
RT   family bromodomains.";
RL   J. Med. Chem. 54:3827-3838(2011).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 44-168 IN COMPLEX WITH JQ1
RP   INHIBITOR.
RX   PubMed=21964340; DOI=10.1038/nature10509;
RA   Dawson M.A., Prinjha R.K., Dittmann A., Giotopoulos G., Bantscheff M.,
RA   Chan W.I., Robson S.C., Chung C.W., Hopf C., Savitski M.M., Huthmacher C.,
RA   Gudgin E., Lugo D., Beinke S., Chapman T.D., Roberts E.J., Soden P.E.,
RA   Auger K.R., Mirguet O., Doehner K., Delwel R., Burnett A.K., Jeffrey P.,
RA   Drewes G., Lee K., Huntly B.J., Kouzarides T.;
RT   "Inhibition of BET recruitment to chromatin as an effective treatment for
RT   MLL-fusion leukaemia.";
RL   Nature 478:529-533(2011).
RN   [44]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 44-168 IN COMPLEX WITH
RP   BENZODIAZEPINES AND BENZOTRIAZEPINES INHIBITORS.
RX   PubMed=22137933; DOI=10.1016/j.bmc.2011.10.080;
RA   Filippakopoulos P., Picaud S., Fedorov O., Keller M., Wrobel M.,
RA   Morgenstern O., Bracher F., Knapp S.;
RT   "Benzodiazepines and benzotriazepines as protein interaction inhibitors
RT   targeting bromodomains of the BET family.";
RL   Bioorg. Med. Chem. 20:1878-1886(2012).
RN   [45]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 44-168, AND STRUCTURE BY NMR OF
RP   333-460.
RX   PubMed=22645123; DOI=10.1074/jbc.m112.359505;
RA   Zhang G., Liu R., Zhong Y., Plotnikov A.N., Zhang W., Zeng L., Rusinova E.,
RA   Gerona-Nevarro G., Moshkina N., Joshua J., Chuang P.Y., Ohlmeyer M.,
RA   He J.C., Zhou M.M.;
RT   "Down-regulation of NF-kappaB transcriptional activity in HIV-associated
RT   kidney disease by BRD4 inhibition.";
RL   J. Biol. Chem. 287:28840-28851(2012).
RN   [46]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 44-168 IN COMPLEX WITH
RP   BENZODIAZEPINES INHIBITORS.
RX   PubMed=22136404; DOI=10.1021/jm201320w;
RA   Chung C.W., Dean A.W., Woolven J.M., Bamborough P.;
RT   "Fragment-based discovery of bromodomain inhibitors part 1: inhibitor
RT   binding modes and implications for lead discovery.";
RL   J. Med. Chem. 55:576-586(2012).
RN   [47]
RP   X-RAY CRYSTALLOGRAPHY (1.92 ANGSTROMS) OF 44-168.
RX   PubMed=23095041; DOI=10.1021/jm3010515;
RA   Fish P.V., Filippakopoulos P., Bish G., Brennan P.E., Bunnage M.E.,
RA   Cook A.S., Federov O., Gerstenberger B.S., Jones H., Knapp S., Marsden B.,
RA   Nocka K., Owen D.R., Philpott M., Picaud S., Primiano M.J., Ralph M.J.,
RA   Sciammetta N., Trzupek J.D.;
RT   "Identification of a chemical probe for bromo and extra C-terminal
RT   bromodomain inhibition through optimization of a fragment-derived hit.";
RL   J. Med. Chem. 55:9831-9837(2012).
RN   [48]
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 44-168; 333-460 AND 1343-1362 IN
RP   COMPLEX WITH ACETYLATED HISTONE, AND MUTAGENESIS OF ASN-140 AND ASN-433.
RX   PubMed=22464331; DOI=10.1016/j.cell.2012.02.013;
RA   Filippakopoulos P., Picaud S., Mangos M., Keates T., Lambert J.P.,
RA   Barsyte-Lovejoy D., Felletar I., Volkmer R., Muller S., Pawson T.,
RA   Gingras A.C., Arrowsmith C.H., Knapp S.;
RT   "Histone recognition and large-scale structural analysis of the human
RT   bromodomain family.";
RL   Cell 149:214-231(2012).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (1.72 ANGSTROMS) OF 44-168 IN COMPLEX WITH
RP   3,5-DIMETHYLISOXAZOLE INHIBITOR.
RX   PubMed=23517011; DOI=10.1021/jm301588r;
RA   Hewings D.S., Fedorov O., Filippakopoulos P., Martin S., Picaud S.,
RA   Tumber A., Wells C., Olcina M.M., Freeman K., Gill A., Ritchie A.J.,
RA   Sheppard D.W., Russell A.J., Hammond E.M., Knapp S., Brennan P.E.,
RA   Conway S.J.;
RT   "Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain
RT   ligands.";
RL   J. Med. Chem. 56:3217-3227(2013).
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (1.43 ANGSTROMS) OF 44-167 IN COMPLEX WITH
RP   2-THIAZOLIDINONE INHIBITOR.
RX   PubMed=23530754; DOI=10.1021/jm301793a;
RA   Zhao L., Cao D., Chen T., Wang Y., Miao Z., Xu Y., Chen W., Wang X., Li Y.,
RA   Du Z., Xiong B., Li J., Xu C., Zhang N., He J., Shen J.;
RT   "Fragment-based drug discovery of 2-thiazolidinones as inhibitors of the
RT   histone reader BRD4 bromodomain.";
RL   J. Med. Chem. 56:3833-3851(2013).
RN   [51] {ECO:0007744|PDB:6BNH}
RP   STRUCTURE BY NMR OF 601-683 IN COMPLEX WITH JMJD6, INTERACTION WITH JMJD6
RP   AND NSD3, MUTAGENESIS OF 651-GLU--GLU-653, AND SUBUNIT.
RX   PubMed=29176719; DOI=10.1038/s41598-017-16588-8;
RA   Konuma T., Yu D., Zhao C., Ju Y., Sharma R., Ren C., Zhang Q., Zhou M.M.,
RA   Zeng L.;
RT   "Structural Mechanism of the Oxygenase JMJD6 Recognition by the
RT   Extraterminal (ET) Domain of BRD4.";
RL   Sci. Rep. 7:16272-16272(2017).
CC   -!- FUNCTION: Chromatin reader protein that recognizes and binds acetylated
CC       histones and plays a key role in transmission of epigenetic memory
CC       across cell divisions and transcription regulation. Remains associated
CC       with acetylated chromatin throughout the entire cell cycle and provides
CC       epigenetic memory for postmitotic G1 gene transcription by preserving
CC       acetylated chromatin status and maintaining high-order chromatin
CC       structure (PubMed:23589332, PubMed:23317504, PubMed:22334664). During
CC       interphase, plays a key role in regulating the transcription of signal-
CC       inducible genes by associating with the P-TEFb complex and recruiting
CC       it to promoters. Also recruits P-TEFb complex to distal enhancers, so
CC       called anti-pause enhancers in collaboration with JMJD6. BRD4 and JMJD6
CC       are required to form the transcriptionally active P-TEFb complex by
CC       displacing negative regulators such as HEXIM1 and 7SKsnRNA complex from
CC       P-TEFb, thereby transforming it into an active form that can then
CC       phosphorylate the C-terminal domain (CTD) of RNA polymerase II
CC       (PubMed:23589332, PubMed:19596240, PubMed:16109377, PubMed:16109376,
CC       PubMed:24360279). Promotes phosphorylation of 'Ser-2' of the C-terminal
CC       domain (CTD) of RNA polymerase II (PubMed:23086925). According to a
CC       report, directly acts as an atypical protein kinase and mediates
CC       phosphorylation of 'Ser-2' of the C-terminal domain (CTD) of RNA
CC       polymerase II; these data however need additional evidences in vivo
CC       (PubMed:22509028). In addition to acetylated histones, also recognizes
CC       and binds acetylated RELA, leading to further recruitment of the P-TEFb
CC       complex and subsequent activation of NF-kappa-B (PubMed:19103749). Also
CC       acts as a regulator of p53/TP53-mediated transcription: following
CC       phosphorylation by CK2, recruited to p53/TP53 specific target promoters
CC       (PubMed:23317504). {ECO:0000269|PubMed:16109376,
CC       ECO:0000269|PubMed:16109377, ECO:0000269|PubMed:19103749,
CC       ECO:0000269|PubMed:19596240, ECO:0000269|PubMed:22334664,
CC       ECO:0000269|PubMed:22509028, ECO:0000269|PubMed:23086925,
CC       ECO:0000269|PubMed:23317504, ECO:0000269|PubMed:23589332,
CC       ECO:0000269|PubMed:24360279}.
CC   -!- FUNCTION: [Isoform B]: Acts as a chromatin insulator in the DNA damage
CC       response pathway. Inhibits DNA damage response signaling by recruiting
CC       the condensin-2 complex to acetylated histones, leading to chromatin
CC       structure remodeling, insulating the region from DNA damage response by
CC       limiting spreading of histone H2AX/H2A.x phosphorylation.
CC       {ECO:0000269|PubMed:23728299}.
CC   -!- SUBUNIT: Binds acetylated histone H4 (PubMed:29176719). Interacts with
CC       p53/TP53; the interaction is direct (PubMed:23317504). Interacts (via
CC       CTD region) with CDK9 and CCNT1, acting as an associated component of
CC       P-TEFb complex (PubMed:16109376, PubMed:16109377, PubMed:23317504,
CC       PubMed:24360279). Interacts with RELA (when acetylated at 'Lys-
CC       310')(PubMed:19103749). Interacts (via NET domain) with NSD3, CHD4,
CC       BICRA and ATAD5 (PubMed:21555454,PubMed:29176719). The interaction with
CC       BICRA bridges BRD4 to the GBAF complex (PubMed:29374058,
CC       PubMed:16109376, PubMed:16109377, PubMed:19103749, PubMed:21555454,
CC       PubMed:23317504). Interacts (via NET domain) with JMJD6 (via JmjC and
CC       N-terminal domains); the interaction is stronger in presence of ssRNA
CC       and recruits JMJD6 on distal enhancers (PubMed:24360279,
CC       PubMed:21555454, PubMed:29176719). Interacts with NSD3
CC       (PubMed:29176719). Isoform B: interacts with NCAPD3 and SMC2
CC       (PubMed:23728299). {ECO:0000269|PubMed:16109376,
CC       ECO:0000269|PubMed:16109377, ECO:0000269|PubMed:19103749,
CC       ECO:0000269|PubMed:21555454, ECO:0000269|PubMed:23317504,
CC       ECO:0000269|PubMed:23728299, ECO:0000269|PubMed:24360279,
CC       ECO:0000269|PubMed:29176719, ECO:0000269|PubMed:29374058}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with bovine papillomavirus
CC       type 1 regulatory protein E2. This interactions may serve for the
CC       tethering of viral genomes to host mitotic chromosomes allowing
CC       successful partitioning of the viral genome during cell division.
CC       {ECO:0000269|PubMed:17189189}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Epstein-Barr virus (EBV)
CC       protein EBNA1; this interaction facilitates transcriptional activation
CC       by EBNA1. {ECO:0000269|PubMed:18922874}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human herpes virus-8
CC       (HHV-8) protein LANA. {ECO:0000269|PubMed:16940503}.
CC   -!- INTERACTION:
CC       O60885; Q86YD7: FAM90A1; NbExp=5; IntAct=EBI-723869, EBI-6658203;
CC       O60885; P62993: GRB2; NbExp=2; IntAct=EBI-723869, EBI-401755;
CC       O60885; Q6NYC1: JMJD6; NbExp=10; IntAct=EBI-723869, EBI-8464037;
CC       O60885; P16333: NCK1; NbExp=2; IntAct=EBI-723869, EBI-389883;
CC       O60885; Q04206: RELA; NbExp=8; IntAct=EBI-723869, EBI-73886;
CC       O60885; A6NLX3: SPDYE4; NbExp=4; IntAct=EBI-723869, EBI-12047907;
CC       O60885; Q15672: TWIST1; NbExp=7; IntAct=EBI-723869, EBI-1797287;
CC       O60885; P03120: E2; Xeno; NbExp=4; IntAct=EBI-723869, EBI-1779322;
CC       O60885; P04015: E2; Xeno; NbExp=3; IntAct=EBI-723869, EBI-7010556;
CC       O60885; P06790: E2; Xeno; NbExp=2; IntAct=EBI-723869, EBI-7010629;
CC       O60885; P17383: E2; Xeno; NbExp=2; IntAct=EBI-723869, EBI-7010529;
CC       O60885-1; P10275: AR; NbExp=6; IntAct=EBI-9345088, EBI-608057;
CC       O60885-1; O60563: CCNT1; NbExp=6; IntAct=EBI-9345088, EBI-2479671;
CC       O60885-1; P50750: CDK9; NbExp=9; IntAct=EBI-9345088, EBI-1383449;
CC       O60885-1; P62805: H4C9; NbExp=10; IntAct=EBI-9345088, EBI-302023;
CC       O60885-1; Q15672: TWIST1; NbExp=9; IntAct=EBI-9345088, EBI-1797287;
CC       O60885-1; P03120: E2; Xeno; NbExp=2; IntAct=EBI-9345088, EBI-1779322;
CC       O60885-1; P03122: E2; Xeno; NbExp=2; IntAct=EBI-9345088, EBI-7028618;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16109376}. Chromosome
CC       {ECO:0000269|PubMed:16109376, ECO:0000269|PubMed:21890894}.
CC       Note=Associates with acetylated chromatin (PubMed:21890894,
CC       PubMed:16109376). Released from chromatin upon deacetylation of
CC       histones that can be triggered by different signals such as activation
CC       of the JNK pathway or nocodazole treatment (PubMed:21890894,
CC       PubMed:16109376). Preferentially localizes to mitotic chromosomes,
CC       while it does not localizes to meiotic chromosomes (PubMed:21890894,
CC       PubMed:16109376). {ECO:0000269|PubMed:16109376,
CC       ECO:0000269|PubMed:21890894}.
CC   -!- SUBCELLULAR LOCATION: [Isoform B]: Chromosome
CC       {ECO:0000269|PubMed:23728299}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=A; Synonyms=Brd4L, Long;
CC         IsoId=O60885-1; Sequence=Displayed;
CC       Name=C; Synonyms=Brd4S, Short;
CC         IsoId=O60885-2; Sequence=VSP_010902, VSP_010903;
CC       Name=B;
CC         IsoId=O60885-3; Sequence=VSP_047671;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:12543779}.
CC   -!- DOMAIN: The NET domain mediates interaction with a number of chromatin
CC       proteins involved in transcription regulation (NSD3, JMJD6, CHD4,
CC       GLTSCR1 and ATAD5). {ECO:0000269|PubMed:21555454}.
CC   -!- DOMAIN: The C-terminal (CTD) region mediates interaction and
CC       recruitment of CDK9 and CCNT1 subunits of the P-TEFb complex
CC       (PubMed:16109376, PubMed:16109377). It is also required for maintenance
CC       of higher-order chromatin structure (PubMed:22334664).
CC       {ECO:0000269|PubMed:16109376, ECO:0000269|PubMed:16109377,
CC       ECO:0000269|PubMed:22334664}.
CC   -!- DOMAIN: The 2 bromo domains mediate specific binding to acetylated
CC       histones via Asn-140 and Asn-433, respectively (PubMed:20871596). The
CC       exact combination of modified histone tails required to recruit BRD4 to
CC       target genes is still unclear. The first bromo domain has high affinity
CC       for acetylated histone H4 tail, whereas the second bromo domain
CC       recognizes multiply acetylated marks in histone H3 (PubMed:22464331). A
CC       number of specific inhibitors bind competitively to acetyl-lysine-
CC       binding residues Asn-140 and Asn-433, promoting removal from acetylated
CC       histones. Many of these inhibitors are benzodiazepine derivatives
CC       (PubMed:22137933, PubMed:22136404, PubMed:23517011, PubMed:23530754).
CC       {ECO:0000269|PubMed:20871596, ECO:0000269|PubMed:22136404,
CC       ECO:0000269|PubMed:22137933, ECO:0000269|PubMed:22464331,
CC       ECO:0000269|PubMed:23517011, ECO:0000269|PubMed:23530754}.
CC   -!- PTM: Phosphorylation by CK2 disrupt the intramolecular binding between
CC       the bromo domain 2 and the NPS region and promotes binding between the
CC       NPS and the BID regions, leading to activate the protein and promote
CC       binding to acetylated histones. In absence of phosphorylation, BRD4
CC       does not localize to p53/TP53 target gene promoters, phosphorylation
CC       promoting recruitment to p53/TP53 target promoters.
CC       {ECO:0000269|PubMed:23317504}.
CC   -!- DISEASE: Note=A chromosomal aberration involving BRD4 is found in a
CC       rare, aggressive, and lethal carcinoma arising in midline organs of
CC       young people. Translocation t(15;19)(q14;p13) with NUTM1 which produces
CC       a BRD4-NUTM1 fusion protein. {ECO:0000269|PubMed:11733348,
CC       ECO:0000269|PubMed:12543779}.
CC   -!- MISCELLANEOUS: Some specific inhibitors of BRD4 that prevent binding to
CC       acetylated histones by binding Asn-140 and Asn-433 are promising
CC       therapeutic molecules for the treatment of leukemias. JQ1, a thieno-
CC       triazolo-1,4-diazepine derivative, and I-BET, a benzodiazepine
CC       derivative, have been tested on tumors with success (PubMed:20871596,
CC       PubMed:21068722, PubMed:21964340). Treatment with GSK1210151A (I-
CC       BET151, a I-BET derivative) has strong effets on mixed lineage leukemia
CC       and promotes myeloid differentiation and leukemia stem-cell depletion
CC       (PubMed:21964340). {ECO:0000305|PubMed:20871596,
CC       ECO:0000305|PubMed:21068722, ECO:0000305|PubMed:21964340}.
CC   -!- MISCELLANEOUS: [Isoform B]: Does not contain the C-terminal (CTD)
CC       region required to recruit the P-TEFb complex. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC27978.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/BRD4ID837ch19p13.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF386649; AAL26987.1; -; mRNA.
DR   EMBL; Y12059; CAA72780.1; -; mRNA.
DR   EMBL; AC004798; AAC27978.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AC003111; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005776; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471106; EAW84470.1; -; Genomic_DNA.
DR   EMBL; BC035266; AAH35266.1; -; mRNA.
DR   EMBL; AY166680; AAO22237.1; ALT_TERM; mRNA.
DR   CCDS; CCDS12328.1; -. [O60885-1]
DR   CCDS; CCDS46004.1; -. [O60885-2]
DR   CCDS; CCDS82307.1; -. [O60885-3]
DR   RefSeq; NP_001317313.1; NM_001330384.1. [O60885-3]
DR   RefSeq; NP_055114.1; NM_014299.2. [O60885-2]
DR   RefSeq; NP_490597.1; NM_058243.2. [O60885-1]
DR   RefSeq; XP_011526156.1; XM_011527854.1.
DR   RefSeq; XP_011526158.1; XM_011527856.2.
DR   PDB; 2I8N; NMR; -; A=352-457.
DR   PDB; 2LSP; NMR; -; B=333-460.
DR   PDB; 2MJV; NMR; -; B=333-460.
DR   PDB; 2N3K; NMR; -; A=600-678.
DR   PDB; 2NCZ; NMR; -; A=601-683.
DR   PDB; 2ND0; NMR; -; A=601-683.
DR   PDB; 2ND1; NMR; -; A=601-683.
DR   PDB; 2NNU; X-ray; 1.59 A; B=1343-1362.
DR   PDB; 2OSS; X-ray; 1.35 A; A=44-168.
DR   PDB; 2OUO; X-ray; 1.89 A; A=333-460.
DR   PDB; 2YEL; X-ray; 1.65 A; A=44-168.
DR   PDB; 2YEM; X-ray; 2.30 A; A/B=333-460.
DR   PDB; 3MXF; X-ray; 1.60 A; A=42-168.
DR   PDB; 3P5O; X-ray; 1.60 A; A=44-168.
DR   PDB; 3SVF; X-ray; 1.98 A; A=44-168.
DR   PDB; 3SVG; X-ray; 1.68 A; A=44-168.
DR   PDB; 3U5J; X-ray; 1.60 A; A=44-168.
DR   PDB; 3U5K; X-ray; 1.80 A; A/B/C/D=44-168.
DR   PDB; 3U5L; X-ray; 1.39 A; A=44-168.
DR   PDB; 3UVW; X-ray; 1.37 A; A=44-168.
DR   PDB; 3UVX; X-ray; 1.91 A; A=44-168.
DR   PDB; 3UVY; X-ray; 2.02 A; A=44-168.
DR   PDB; 3UW9; X-ray; 2.30 A; A/B/C/D=44-168.
DR   PDB; 3ZYU; X-ray; 1.50 A; A/B=44-168.
DR   PDB; 4A9L; X-ray; 1.60 A; A=44-168.
DR   PDB; 4BJX; X-ray; 1.59 A; A=44-168.
DR   PDB; 4BW1; X-ray; 1.40 A; A=44-168.
DR   PDB; 4BW2; X-ray; 1.92 A; A=44-168.
DR   PDB; 4BW3; X-ray; 1.50 A; A=44-168.
DR   PDB; 4BW4; X-ray; 1.67 A; A=44-168.
DR   PDB; 4C66; X-ray; 1.87 A; A=44-167.
DR   PDB; 4C67; X-ray; 1.55 A; A=44-168.
DR   PDB; 4CFK; X-ray; 1.55 A; A=44-168.
DR   PDB; 4CFL; X-ray; 1.32 A; A=44-168.
DR   PDB; 4CL9; X-ray; 1.40 A; A=44-168.
DR   PDB; 4CLB; X-ray; 1.60 A; A=44-168.
DR   PDB; 4DON; X-ray; 1.52 A; A=44-166.
DR   PDB; 4E96; X-ray; 1.92 A; A=44-168.
DR   PDB; 4F3I; X-ray; 1.40 A; A=44-168.
DR   PDB; 4GPJ; X-ray; 1.60 A; A=44-168.
DR   PDB; 4HBV; X-ray; 1.63 A; A=42-168.
DR   PDB; 4HBW; X-ray; 1.69 A; A=42-168.
DR   PDB; 4HBX; X-ray; 1.62 A; A=42-168.
DR   PDB; 4HBY; X-ray; 1.59 A; A=44-168.
DR   PDB; 4HXK; X-ray; 1.61 A; A=44-167.
DR   PDB; 4HXL; X-ray; 1.52 A; A=44-167.
DR   PDB; 4HXM; X-ray; 1.50 A; A=44-166.
DR   PDB; 4HXN; X-ray; 1.49 A; A=44-167.
DR   PDB; 4HXO; X-ray; 1.76 A; A=44-167.
DR   PDB; 4HXP; X-ray; 1.73 A; A=44-166.
DR   PDB; 4HXR; X-ray; 1.53 A; A=44-167.
DR   PDB; 4HXS; X-ray; 1.43 A; A=44-166.
DR   PDB; 4IOO; X-ray; 1.25 A; A=44-168.
DR   PDB; 4IOQ; X-ray; 1.50 A; A=44-168.
DR   PDB; 4IOR; X-ray; 1.40 A; A=44-168.
DR   PDB; 4J0R; X-ray; 1.72 A; A=44-168.
DR   PDB; 4J0S; X-ray; 1.84 A; A=44-168.
DR   PDB; 4J3I; X-ray; 1.24 A; A=44-168.
DR   PDB; 4KV1; X-ray; 1.50 A; A/B=41-168.
DR   PDB; 4KV4; X-ray; 2.00 A; A=351-459.
DR   PDB; 4LR6; X-ray; 1.29 A; A=42-168.
DR   PDB; 4LRG; X-ray; 2.21 A; A=42-168.
DR   PDB; 4LYI; X-ray; 1.30 A; A=44-168.
DR   PDB; 4LYS; X-ray; 1.83 A; A=44-168.
DR   PDB; 4LYW; X-ray; 1.95 A; A=44-168.
DR   PDB; 4LZR; X-ray; 1.85 A; A=44-168.
DR   PDB; 4LZS; X-ray; 2.20 A; A=44-168.
DR   PDB; 4MEN; X-ray; 1.81 A; A=44-168.
DR   PDB; 4MEO; X-ray; 1.72 A; A=44-168.
DR   PDB; 4MEP; X-ray; 1.85 A; A=44-168.
DR   PDB; 4MEQ; X-ray; 1.77 A; A=44-168.
DR   PDB; 4MR3; X-ray; 1.68 A; A=44-168.
DR   PDB; 4MR4; X-ray; 1.66 A; A=44-168.
DR   PDB; 4NQM; X-ray; 1.58 A; A=44-168.
DR   PDB; 4NR8; X-ray; 1.64 A; A=44-168.
DR   PDB; 4NUC; X-ray; 1.40 A; A=44-168.
DR   PDB; 4NUD; X-ray; 1.20 A; A=44-168.
DR   PDB; 4NUE; X-ray; 1.30 A; A=44-168.
DR   PDB; 4O70; X-ray; 1.55 A; A/B=44-168.
DR   PDB; 4O71; X-ray; 1.36 A; A/B=44-168.
DR   PDB; 4O72; X-ray; 1.40 A; A=44-168.
DR   PDB; 4O74; X-ray; 1.45 A; A/B=44-168.
DR   PDB; 4O75; X-ray; 1.55 A; A=44-168.
DR   PDB; 4O76; X-ray; 1.70 A; A/B/C/D=44-168.
DR   PDB; 4O77; X-ray; 2.00 A; A/B=44-168.
DR   PDB; 4O78; X-ray; 1.34 A; A=44-168.
DR   PDB; 4O7A; X-ray; 1.34 A; A=44-168.
DR   PDB; 4O7B; X-ray; 1.50 A; A=44-168.
DR   PDB; 4O7C; X-ray; 1.55 A; A=44-168.
DR   PDB; 4O7E; X-ray; 1.85 A; A/B=44-168.
DR   PDB; 4O7F; X-ray; 1.80 A; A/B=44-168.
DR   PDB; 4OGI; X-ray; 1.73 A; A/B=44-168.
DR   PDB; 4OGJ; X-ray; 1.65 A; A/B=44-168.
DR   PDB; 4PCE; X-ray; 1.29 A; A=44-168.
DR   PDB; 4PCI; X-ray; 1.25 A; A=44-168.
DR   PDB; 4PS5; X-ray; 1.40 A; A/B=44-168.
DR   PDB; 4QB3; X-ray; 0.94 A; A=44-168.
DR   PDB; 4QR3; X-ray; 1.37 A; A=44-166.
DR   PDB; 4QR4; X-ray; 1.28 A; A=44-166.
DR   PDB; 4QR5; X-ray; 1.41 A; A=44-166.
DR   PDB; 4QZS; X-ray; 1.45 A; A=44-168.
DR   PDB; 4UIX; X-ray; 1.58 A; A/B/C=44-168.
DR   PDB; 4UIY; X-ray; 1.30 A; A=44-168.
DR   PDB; 4UIZ; X-ray; 1.19 A; A=44-168.
DR   PDB; 4UYD; X-ray; 1.37 A; A=44-183.
DR   PDB; 4WHW; X-ray; 1.34 A; A=44-168.
DR   PDB; 4WIV; X-ray; 1.56 A; A=44-168.
DR   PDB; 4X2I; X-ray; 1.20 A; A=42-166.
DR   PDB; 4XY9; X-ray; 1.83 A; A=42-168.
DR   PDB; 4XYA; X-ray; 2.05 A; A=42-168.
DR   PDB; 4YH3; X-ray; 1.60 A; A=44-170.
DR   PDB; 4YH4; X-ray; 1.33 A; A=44-170.
DR   PDB; 4Z1Q; X-ray; 1.40 A; A/B=42-167.
DR   PDB; 4Z1S; X-ray; 1.06 A; A/B=42-166.
DR   PDB; 4Z93; X-ray; 1.27 A; A=349-460.
DR   PDB; 4ZC9; X-ray; 0.99 A; A=44-168.
DR   PDB; 4ZW1; X-ray; 1.75 A; A=44-168.
DR   PDB; 5A5S; X-ray; 1.36 A; A=44-168.
DR   PDB; 5A85; X-ray; 1.72 A; A=44-168.
DR   PDB; 5ACY; X-ray; 2.01 A; A/B=44-168.
DR   PDB; 5AD2; X-ray; 2.01 A; A/B=44-168.
DR   PDB; 5AD3; X-ray; 1.49 A; A/B=44-168.
DR   PDB; 5BT4; X-ray; 1.50 A; A/B/C=44-168.
DR   PDB; 5CFW; X-ray; 1.15 A; A=44-168.
DR   PDB; 5COI; X-ray; 1.62 A; A=44-168.
DR   PDB; 5CP5; X-ray; 1.79 A; A=44-168.
DR   PDB; 5CPE; X-ray; 1.62 A; A=44-168.
DR   PDB; 5CQT; X-ray; 1.60 A; A=44-168.
DR   PDB; 5CRM; X-ray; 1.99 A; A=44-168.
DR   PDB; 5CRZ; X-ray; 2.12 A; A=44-168.
DR   PDB; 5CS8; X-ray; 1.62 A; A=44-168.
DR   PDB; 5CTL; X-ray; 2.51 A; A=44-168.
DR   PDB; 5CY9; X-ray; 1.55 A; A=44-168.
DR   PDB; 5D0C; X-ray; 1.49 A; A=44-168.
DR   PDB; 5D24; X-ray; 1.65 A; A=43-168.
DR   PDB; 5D25; X-ray; 1.70 A; A=43-168.
DR   PDB; 5D26; X-ray; 1.82 A; A=42-168.
DR   PDB; 5D3H; X-ray; 1.70 A; A=44-168.
DR   PDB; 5D3J; X-ray; 1.70 A; A=43-168.
DR   PDB; 5D3L; X-ray; 1.50 A; A=42-168.
DR   PDB; 5D3N; X-ray; 2.15 A; A=43-168.
DR   PDB; 5D3P; X-ray; 1.95 A; A=42-168.
DR   PDB; 5D3R; X-ray; 2.20 A; A=42-168.
DR   PDB; 5D3S; X-ray; 1.75 A; A=44-168.
DR   PDB; 5D3T; X-ray; 1.93 A; A=42-168.
DR   PDB; 5DLX; X-ray; 1.90 A; A=44-168.
DR   PDB; 5DLZ; X-ray; 1.70 A; A=44-168.
DR   PDB; 5DW2; X-ray; 1.12 A; A=44-170.
DR   PDB; 5DX4; X-ray; 2.30 A; A=44-168.
DR   PDB; 5E0R; X-ray; 1.35 A; A=44-168.
DR   PDB; 5EGU; X-ray; 2.21 A; A/B/C/D=44-168.
DR   PDB; 5EI4; X-ray; 1.05 A; A=44-168.
DR   PDB; 5EIS; X-ray; 1.60 A; A=44-168.
DR   PDB; 5F5Z; X-ray; 1.76 A; A=44-168.
DR   PDB; 5F60; X-ray; 1.35 A; A=44-168.
DR   PDB; 5F61; X-ray; 1.45 A; A/B=44-168.
DR   PDB; 5F62; X-ray; 1.35 A; A=44-168.
DR   PDB; 5F63; X-ray; 1.45 A; A=44-168.
DR   PDB; 5FBX; X-ray; 1.85 A; A=44-168.
DR   PDB; 5H21; X-ray; 1.59 A; A=44-167.
DR   PDB; 5HCL; X-ray; 1.50 A; A=44-168.
DR   PDB; 5HLS; X-ray; 2.18 A; A=42-168.
DR   PDB; 5HM0; X-ray; 1.40 A; A=42-168.
DR   PDB; 5HQ5; X-ray; 1.60 A; A=44-168.
DR   PDB; 5HQ6; X-ray; 1.95 A; A=44-166.
DR   PDB; 5HQ7; X-ray; 1.90 A; A=44-167.
DR   PDB; 5I80; X-ray; 1.45 A; A=42-167.
DR   PDB; 5I88; X-ray; 1.40 A; A=42-167.
DR   PDB; 5IGK; X-ray; 1.70 A; A=44-168.
DR   PDB; 5JWM; X-ray; 1.71 A; A/B=333-460.
DR   PDB; 5KDH; X-ray; 1.50 A; A=44-168.
DR   PDB; 5KHM; X-ray; 1.48 A; A/B=44-168.
DR   PDB; 5KJ0; X-ray; 1.51 A; A=44-168.
DR   PDB; 5KU3; X-ray; 1.14 A; A=42-167.
DR   PDB; 5LJ1; X-ray; 1.90 A; A=42-168.
DR   PDB; 5LJ2; X-ray; 1.19 A; A=42-168.
DR   PDB; 5LRQ; X-ray; 1.70 A; A=42-163.
DR   PDB; 5LUU; X-ray; 1.61 A; A=44-168.
DR   PDB; 5M39; X-ray; 1.38 A; A/B=42-168.
DR   PDB; 5M3A; X-ray; 1.65 A; A=44-168.
DR   PDB; 5MKZ; X-ray; 1.62 A; A=44-168.
DR   PDB; 5MLI; X-ray; 1.63 A; A=42-168.
DR   PDB; 5N2M; X-ray; 1.54 A; A=44-168.
DR   PDB; 5NNC; X-ray; 2.22 A; A/B=44-168.
DR   PDB; 5NND; X-ray; 1.82 A; A/B=44-168.
DR   PDB; 5NNE; X-ray; 1.15 A; A=44-168.
DR   PDB; 5NNF; X-ray; 1.15 A; A=44-168.
DR   PDB; 5NNG; X-ray; 1.20 A; A=44-168.
DR   PDB; 5O97; X-ray; 1.30 A; A=44-168.
DR   PDB; 5OVB; X-ray; 1.95 A; A/B=44-168.
DR   PDB; 5OWM; X-ray; 1.50 A; A=44-168.
DR   PDB; 5OWW; X-ray; 1.50 A; A/B/C/D=44-168.
DR   PDB; 5S9P; X-ray; 2.10 A; A/B/D/E=44-168.
DR   PDB; 5S9Q; X-ray; 1.85 A; A/B/D/E=44-168.
DR   PDB; 5S9R; X-ray; 1.85 A; A=44-168.
DR   PDB; 5T35; X-ray; 2.70 A; A/E=333-460.
DR   PDB; 5TI2; X-ray; 1.65 A; A=44-168.
DR   PDB; 5TI3; X-ray; 1.70 A; A=44-168.
DR   PDB; 5TI4; X-ray; 1.62 A; A=44-168.
DR   PDB; 5TI5; X-ray; 1.83 A; A=44-168.
DR   PDB; 5TI6; X-ray; 1.70 A; A=44-168.
DR   PDB; 5TI7; X-ray; 1.65 A; A=44-168.
DR   PDB; 5U28; X-ray; 1.80 A; A=44-180.
DR   PDB; 5U2C; X-ray; 3.30 A; A/B=342-460.
DR   PDB; 5U2E; X-ray; 1.99 A; A/B=42-180.
DR   PDB; 5U2F; X-ray; 2.52 A; A/B=42-180.
DR   PDB; 5UEO; X-ray; 1.85 A; A/B=352-457.
DR   PDB; 5UEP; X-ray; 1.77 A; A=352-457.
DR   PDB; 5UEQ; X-ray; 1.70 A; A=352-457.
DR   PDB; 5UER; X-ray; 1.87 A; A=352-457.
DR   PDB; 5UES; X-ray; 1.62 A; A=352-457.
DR   PDB; 5UET; X-ray; 2.29 A; A=352-457.
DR   PDB; 5UEU; X-ray; 2.26 A; A/B=352-457.
DR   PDB; 5UEV; X-ray; 1.94 A; A=352-457.
DR   PDB; 5UEX; X-ray; 2.29 A; A=352-457.
DR   PDB; 5UEY; X-ray; 2.41 A; A=352-457.
DR   PDB; 5UEZ; X-ray; 1.51 A; A=352-457.
DR   PDB; 5UF0; X-ray; 1.35 A; A=352-457.
DR   PDB; 5ULA; X-ray; 1.50 A; A/B=44-168.
DR   PDB; 5UOO; X-ray; 1.69 A; A=333-460.
DR   PDB; 5UVS; X-ray; 2.15 A; A=352-457.
DR   PDB; 5UVT; X-ray; 1.67 A; A=352-457.
DR   PDB; 5UVU; X-ray; 1.66 A; A=352-457.
DR   PDB; 5UVV; X-ray; 1.99 A; A/B=352-457.
DR   PDB; 5UVW; X-ray; 2.14 A; A/B/C=57-165.
DR   PDB; 5UVX; X-ray; 1.53 A; A/B=352-457.
DR   PDB; 5UVY; X-ray; 2.25 A; A=352-457.
DR   PDB; 5UVZ; X-ray; 1.63 A; A=352-457.
DR   PDB; 5V67; X-ray; 1.78 A; A=44-168.
DR   PDB; 5VBO; X-ray; 1.30 A; A=44-168.
DR   PDB; 5VBP; X-ray; 1.83 A; A/B=44-168.
DR   PDB; 5VOM; X-ray; 1.67 A; A/B=44-168.
DR   PDB; 5VZS; X-ray; 1.71 A; A/B=42-168.
DR   PDB; 5W55; X-ray; 1.35 A; A=42-168.
DR   PDB; 5WA5; X-ray; 1.17 A; A=42-168.
DR   PDB; 5WMA; X-ray; 1.40 A; A=44-168.
DR   PDB; 5WMD; X-ray; 1.27 A; A=44-168.
DR   PDB; 5WMG; X-ray; 1.19 A; A=44-168.
DR   PDB; 5WUU; X-ray; 1.72 A; A=44-167.
DR   PDB; 5XHY; X-ray; 1.98 A; A=44-166.
DR   PDB; 5XI2; X-ray; 1.91 A; A=44-166.
DR   PDB; 5XI3; X-ray; 1.67 A; A=44-166.
DR   PDB; 5XI4; X-ray; 1.49 A; A=44-166.
DR   PDB; 5Y1Y; X-ray; 1.91 A; A=44-167.
DR   PDB; 5Y8C; X-ray; 1.42 A; A=44-166.
DR   PDB; 5Y8W; X-ray; 1.76 A; A=44-168.
DR   PDB; 5Y8Y; X-ray; 1.87 A; A=44-168.
DR   PDB; 5Y8Z; X-ray; 1.84 A; A=44-168.
DR   PDB; 5Y93; X-ray; 1.62 A; A=44-168.
DR   PDB; 5Y94; X-ray; 2.00 A; A=44-168.
DR   PDB; 5YOU; X-ray; 1.50 A; A=42-168.
DR   PDB; 5YOV; X-ray; 1.45 A; A=42-168.
DR   PDB; 5YQX; X-ray; 1.82 A; A=44-167.
DR   PDB; 5Z1R; X-ray; 1.62 A; A=44-168.
DR   PDB; 5Z1S; X-ray; 1.42 A; A=44-168.
DR   PDB; 5Z1T; X-ray; 1.42 A; A=44-168.
DR   PDB; 5Z5T; X-ray; 1.99 A; A=44-167.
DR   PDB; 5Z5U; X-ray; 1.63 A; A=44-167.
DR   PDB; 5Z5V; X-ray; 1.66 A; A=44-167.
DR   PDB; 5Z8G; X-ray; 1.70 A; A=44-168.
DR   PDB; 5Z8R; X-ray; 2.00 A; A=44-168.
DR   PDB; 5Z8Z; X-ray; 1.80 A; A=44-168.
DR   PDB; 5Z90; X-ray; 1.80 A; A=44-168.
DR   PDB; 5Z9C; NMR; -; A=53-168.
DR   PDB; 5Z9K; X-ray; 1.89 A; A=44-168.
DR   PDB; 6AFR; X-ray; 2.00 A; A=44-168.
DR   PDB; 6AJV; X-ray; 1.45 A; A=42-168.
DR   PDB; 6AJW; X-ray; 1.40 A; A=42-168.
DR   PDB; 6AJX; X-ray; 1.89 A; A=42-168.
DR   PDB; 6AJY; X-ray; 1.60 A; A=42-168.
DR   PDB; 6AJZ; Other; 1.30 A; A=42-168.
DR   PDB; 6BN7; X-ray; 3.50 A; C=42-168.
DR   PDB; 6BN8; X-ray; 3.99 A; C=42-168.
DR   PDB; 6BN9; X-ray; 4.38 A; C=42-168.
DR   PDB; 6BNB; X-ray; 6.34 A; C=42-168.
DR   PDB; 6BNH; NMR; -; A=601-683.
DR   PDB; 6BOY; X-ray; 3.33 A; C=42-168.
DR   PDB; 6C7Q; X-ray; 1.51 A; A=333-460.
DR   PDB; 6C7R; X-ray; 1.50 A; A=44-165.
DR   PDB; 6CD4; X-ray; 1.23 A; A=42-168.
DR   PDB; 6CD5; X-ray; 1.58 A; A=44-168.
DR   PDB; 6CIS; X-ray; 1.51 A; A=44-166.
DR   PDB; 6CIY; X-ray; 1.68 A; A=44-168.
DR   PDB; 6CJ1; X-ray; 1.53 A; A=44-166.
DR   PDB; 6CJ2; X-ray; 1.47 A; A=42-166.
DR   PDB; 6CKR; X-ray; 1.62 A; A/B=44-168.
DR   PDB; 6CKS; X-ray; 1.72 A; A=44-168.
DR   PDB; 6CZU; X-ray; 1.47 A; A=42-170.
DR   PDB; 6CZV; X-ray; 1.88 A; A=42-170.
DR   PDB; 6DJC; X-ray; 1.46 A; A/B=44-173.
DR   PDB; 6DL2; X-ray; 1.47 A; A=44-168.
DR   PDB; 6DMJ; X-ray; 1.15 A; A=44-168.
DR   PDB; 6DML; X-ray; 1.50 A; A=44-168.
DR   PDB; 6DNE; X-ray; 2.96 A; A/B=44-477.
DR   PDB; 6DUV; X-ray; 1.80 A; A/B=347-458.
DR   PDB; 6E4A; X-ray; 1.26 A; A/B=44-170.
DR   PDB; 6FFD; X-ray; 1.83 A; A=347-463.
DR   PDB; 6FNX; X-ray; 1.19 A; A=44-168.
DR   PDB; 6FO5; X-ray; 0.95 A; A=44-168.
DR   PDB; 6FSY; X-ray; 1.34 A; A=42-168.
DR   PDB; 6FT3; X-ray; 1.28 A; A=42-168.
DR   PDB; 6FT4; X-ray; 1.34 A; A=42-168.
DR   PDB; 6G0D; X-ray; 1.31 A; A=42-168.
DR   PDB; 6G0E; X-ray; 1.61 A; A=42-168.
DR   PDB; 6G0F; X-ray; 1.62 A; A=42-168.
DR   PDB; 6G0G; X-ray; 1.48 A; A=42-168.
DR   PDB; 6G0H; X-ray; 1.91 A; A=42-168.
DR   PDB; 6G0O; X-ray; 1.40 A; A=42-168.
DR   PDB; 6G0P; X-ray; 1.30 A; A=42-168.
DR   PDB; 6G0Q; X-ray; 1.40 A; A=42-168.
DR   PDB; 6G0R; X-ray; 1.25 A; A=42-168.
DR   PDB; 6G0S; X-ray; 1.48 A; A/B=42-168.
DR   PDB; 6HDQ; X-ray; 1.70 A; A=44-168.
DR   PDB; 6HOV; X-ray; 1.85 A; A=44-168.
DR   PDB; 6I7X; X-ray; 1.20 A; A=44-168.
DR   PDB; 6I7Y; X-ray; 1.00 A; A=44-168.
DR   PDB; 6IN1; X-ray; 1.50 A; A=42-168.
DR   PDB; 6JI3; X-ray; 2.20 A; A=44-166.
DR   PDB; 6JI4; X-ray; 1.60 A; A=44-166.
DR   PDB; 6JI5; X-ray; 2.00 A; A=44-166.
DR   PDB; 6JJ3; X-ray; 1.72 A; A=44-167.
DR   PDB; 6JJ5; X-ray; 1.20 A; A=44-167.
DR   PDB; 6JJ6; X-ray; 1.40 A; A=44-167.
DR   PDB; 6JJB; X-ray; 1.51 A; A=44-167.
DR   PDB; 6KEC; X-ray; 1.35 A; A=44-168.
DR   PDB; 6KED; X-ray; 2.55 A; A=44-168.
DR   PDB; 6KEE; X-ray; 2.12 A; A=44-168.
DR   PDB; 6KEF; X-ray; 2.44 A; A=44-168.
DR   PDB; 6KEG; X-ray; 2.23 A; A=44-168.
DR   PDB; 6KEH; X-ray; 1.55 A; A=44-168.
DR   PDB; 6KEI; X-ray; 1.45 A; A=44-168.
DR   PDB; 6KEJ; X-ray; 1.85 A; A=44-168.
DR   PDB; 6KEK; X-ray; 1.55 A; A=44-168.
DR   PDB; 6KO2; X-ray; 1.50 A; A=351-457.
DR   PDB; 6LG4; X-ray; 1.85 A; A=44-167.
DR   PDB; 6LG5; X-ray; 1.83 A; A=44-167.
DR   PDB; 6LG6; X-ray; 1.98 A; A=44-167.
DR   PDB; 6LG7; X-ray; 1.83 A; A=44-167.
DR   PDB; 6LG8; X-ray; 1.58 A; A=44-167.
DR   PDB; 6LG9; X-ray; 1.81 A; A=44-167.
DR   PDB; 6LIH; X-ray; 1.62 A; A=44-166.
DR   PDB; 6LIM; X-ray; 1.76 A; A=44-166.
DR   PDB; 6MAU; X-ray; 2.11 A; A=44-170.
DR   PDB; 6MH1; X-ray; 1.60 A; A/B=44-168.
DR   PDB; 6MH7; X-ray; 1.74 A; A/B=44-168.
DR   PDB; 6MNL; NMR; -; B=333-460.
DR   PDB; 6P05; X-ray; 1.54 A; A=44-168.
DR   PDB; 6PRT; X-ray; 1.30 A; A=43-168.
DR   PDB; 6PS9; X-ray; 1.21 A; A=44-168.
DR   PDB; 6PSB; X-ray; 1.59 A; A=44-168.
DR   PDB; 6Q3Y; X-ray; 1.20 A; A/B=42-168.
DR   PDB; 6Q3Z; X-ray; 2.00 A; A/B=44-168.
DR   PDB; 6RWJ; X-ray; 1.40 A; A=44-168.
DR   PDB; 6S25; X-ray; 1.10 A; A=44-168.
DR   PDB; 6S4B; X-ray; 1.60 A; A=44-168.
DR   PDB; 6S6K; X-ray; 1.40 A; A=44-168.
DR   PDB; 6SA2; X-ray; 1.50 A; A=44-168.
DR   PDB; 6SA3; X-ray; 1.80 A; A=44-168.
DR   PDB; 6SAH; X-ray; 1.50 A; A=44-168.
DR   PDB; 6SAJ; X-ray; 1.50 A; A=44-168.
DR   PDB; 6SB8; X-ray; 1.50 A; A=44-168.
DR   PDB; 6SE4; X-ray; 1.38 A; A=44-168.
DR   PDB; 6SIS; X-ray; 3.50 A; A/E=333-460.
DR   PDB; 6SWN; X-ray; 1.28 A; AAA=44-168.
DR   PDB; 6SWQ; X-ray; 1.60 A; AAA=44-168.
DR   PDB; 6TPX; X-ray; 1.48 A; AAA=44-168.
DR   PDB; 6TPY; X-ray; 1.80 A; AAA=44-168.
DR   PDB; 6TPZ; X-ray; 1.30 A; AAA=44-168.
DR   PDB; 6U0D; X-ray; 1.43 A; A=44-168.
DR   PDB; 6U6K; X-ray; 1.70 A; A=42-168.
DR   PDB; 6U6L; X-ray; 2.60 A; A=347-464.
DR   PDB; 6U72; X-ray; 2.30 A; A/B=42-168.
DR   PDB; 6U74; X-ray; 1.85 A; A/B/C/D=42-168.
DR   PDB; 6U8G; X-ray; 2.60 A; A/B/C/D=42-168.
DR   PDB; 6U8I; X-ray; 2.50 A; A=347-464.
DR   PDB; 6U8M; X-ray; 1.95 A; A/B=42-168.
DR   PDB; 6ULS; X-ray; 1.50 A; A=42-168.
DR   PDB; 6ULV; X-ray; 2.20 A; A/B/C/D=42-168.
DR   PDB; 6UVJ; X-ray; 1.38 A; A=44-168.
DR   PDB; 6UVM; X-ray; 1.51 A; A=44-168.
DR   PDB; 6UWU; X-ray; 2.00 A; A=44-168.
DR   PDB; 6UWX; X-ray; 1.31 A; A=44-168.
DR   PDB; 6V0U; X-ray; 1.40 A; A=44-168.
DR   PDB; 6V1K; X-ray; 1.75 A; A=44-168.
DR   PDB; 6V1L; X-ray; 2.10 A; A=44-168.
DR   PDB; 6V1U; X-ray; 1.73 A; A=44-168.
DR   PDB; 6VIW; X-ray; 2.43 A; A/B/C=57-168.
DR   PDB; 6VIX; X-ray; 2.12 A; A/B/C/D=352-457.
DR   PDB; 6VIZ; X-ray; 2.39 A; A/B/C=57-168.
DR   PDB; 6VUB; X-ray; 1.50 A; A=44-168.
DR   PDB; 6VUC; X-ray; 1.55 A; A=44-168.
DR   PDB; 6VUF; X-ray; 1.59 A; A/B=44-168.
DR   PDB; 6VUJ; X-ray; 1.48 A; A=44-168.
DR   PDB; 6WGX; X-ray; 1.53 A; A/B=44-168.
DR   PDB; 6WVX; X-ray; 1.55 A; A/B=44-168.
DR   PDB; 6WW8; X-ray; 2.30 A; A=43-180.
DR   PDB; 6X7B; X-ray; 1.95 A; A/B=44-176.
DR   PDB; 6X7C; X-ray; 2.70 A; A=44-176.
DR   PDB; 6X7D; X-ray; 2.50 A; A/B=44-176.
DR   PDB; 6XUZ; X-ray; 1.07 A; A=44-168.
DR   PDB; 6XV3; X-ray; 1.47 A; A/B/C/D=44-168.
DR   PDB; 6XV7; X-ray; 1.67 A; A=44-168.
DR   PDB; 6XVC; X-ray; 1.10 A; B=44-168.
DR   PDB; 6YIN; X-ray; 1.53 A; A=44-168.
DR   PDB; 6YQN; X-ray; 1.05 A; A=44-168.
DR   PDB; 6YQO; X-ray; 1.07 A; A=44-168.
DR   PDB; 6YQP; X-ray; 1.25 A; A=44-168.
DR   PDB; 6YQZ; X-ray; 1.39 A; A=44-168.
DR   PDB; 6Z7G; X-ray; 1.59 A; AAA=44-168.
DR   PDB; 6Z7L; X-ray; 1.62 A; AAA=44-168.
DR   PDB; 6Z7M; X-ray; 1.26 A; AAA=44-168.
DR   PDB; 6ZB3; X-ray; 1.42 A; AAA=44-168.
DR   PDB; 6ZCI; X-ray; 1.98 A; A=44-168.
DR   PDB; 6ZED; X-ray; 1.08 A; AAA=44-168.
DR   PDB; 6ZEL; X-ray; 1.12 A; AAA=44-168.
DR   PDB; 6ZF9; X-ray; 1.20 A; AAA=44-168.
DR   PDB; 7A9U; X-ray; 1.44 A; AAA=44-168.
DR   PDB; 7AJN; X-ray; 1.48 A; A=44-168.
DR   PDB; 7AQT; NMR; -; A=351-459.
DR   PDB; 7AXR; X-ray; 1.50 A; A=44-168.
DR   PDB; 7C2Z; X-ray; 1.30 A; A=44-168.
DR   PDB; 7C6P; X-ray; 1.73 A; A=352-457.
DR   PDB; 7DHS; X-ray; 1.76 A; A/B=44-168.
DR   PDB; 7EHW; X-ray; 1.65 A; A=44-167.
DR   PDB; 7EHY; X-ray; 1.51 A; A=44-167.
DR   PDB; 7EIG; X-ray; 1.30 A; A=44-167.
DR   PDB; 7EIK; X-ray; 1.70 A; A=44-167.
DR   PDB; 7EIL; X-ray; 1.70 A; A=44-167.
DR   PDB; 7JKW; X-ray; 1.20 A; A=44-168.
DR   PDB; 7JKX; X-ray; 1.20 A; A=44-168.
DR   PDB; 7JKY; X-ray; 1.16 A; A=44-168.
DR   PDB; 7JKZ; X-ray; 2.49 A; A=333-460.
DR   PDB; 7K6G; X-ray; 1.70 A; A/B=44-168.
DR   PDB; 7K6H; X-ray; 1.50 A; A=44-168.
DR   PDB; 7KHH; X-ray; 2.28 A; D=44-168.
DR   PDB; 7KHL; X-ray; 1.29 A; A/B=44-168.
DR   PDB; 7KO0; X-ray; 1.90 A; A=349-460.
DR   PDB; 7L9M; X-ray; 1.45 A; A/B=44-168.
DR   PDB; 7LA9; X-ray; 2.20 A; A/B/C/D/E/F=44-168.
DR   PDB; 7M16; X-ray; 1.42 A; A=44-168.
DR   PDB; 7MCE; X-ray; 1.76 A; A=44-168.
DR   PDB; 7MCF; X-ray; 2.19 A; A/B=44-168.
DR   PDB; 7MLQ; X-ray; 1.32 A; A=44-168.
DR   PDB; 7MLR; X-ray; 1.20 A; A=44-168.
DR   PDB; 7MLS; X-ray; 1.26 A; A=44-168.
DR   PDB; 7O18; X-ray; 1.70 A; AAA=44-168.
DR   PDB; 7OEO; X-ray; 1.51 A; AAA=347-463.
DR   PDB; 7P6V; X-ray; 1.17 A; AAA=44-168.
DR   PDB; 7P6W; X-ray; 1.31 A; AAA=44-168.
DR   PDB; 7P6Y; X-ray; 1.88 A; AAA/BBB=44-168.
DR   PDB; 7R9C; X-ray; 1.50 A; A=44-168.
DR   PDB; 7REK; X-ray; 1.20 A; A/B=44-168.
DR   PDB; 7REL; X-ray; 1.55 A; A=44-168.
DR   PDB; 7REM; X-ray; 1.80 A; A=44-168.
DR   PDB; 7RXR; X-ray; 1.41 A; A/B=44-168.
DR   PDB; 7RXS; X-ray; 1.43 A; A=44-168.
DR   PDB; 7RXT; X-ray; 1.68 A; A=44-168.
DR   PDBsum; 2I8N; -.
DR   PDBsum; 2LSP; -.
DR   PDBsum; 2MJV; -.
DR   PDBsum; 2N3K; -.
DR   PDBsum; 2NCZ; -.
DR   PDBsum; 2ND0; -.
DR   PDBsum; 2ND1; -.
DR   PDBsum; 2NNU; -.
DR   PDBsum; 2OSS; -.
DR   PDBsum; 2OUO; -.
DR   PDBsum; 2YEL; -.
DR   PDBsum; 2YEM; -.
DR   PDBsum; 3MXF; -.
DR   PDBsum; 3P5O; -.
DR   PDBsum; 3SVF; -.
DR   PDBsum; 3SVG; -.
DR   PDBsum; 3U5J; -.
DR   PDBsum; 3U5K; -.
DR   PDBsum; 3U5L; -.
DR   PDBsum; 3UVW; -.
DR   PDBsum; 3UVX; -.
DR   PDBsum; 3UVY; -.
DR   PDBsum; 3UW9; -.
DR   PDBsum; 3ZYU; -.
DR   PDBsum; 4A9L; -.
DR   PDBsum; 4BJX; -.
DR   PDBsum; 4BW1; -.
DR   PDBsum; 4BW2; -.
DR   PDBsum; 4BW3; -.
DR   PDBsum; 4BW4; -.
DR   PDBsum; 4C66; -.
DR   PDBsum; 4C67; -.
DR   PDBsum; 4CFK; -.
DR   PDBsum; 4CFL; -.
DR   PDBsum; 4CL9; -.
DR   PDBsum; 4CLB; -.
DR   PDBsum; 4DON; -.
DR   PDBsum; 4E96; -.
DR   PDBsum; 4F3I; -.
DR   PDBsum; 4GPJ; -.
DR   PDBsum; 4HBV; -.
DR   PDBsum; 4HBW; -.
DR   PDBsum; 4HBX; -.
DR   PDBsum; 4HBY; -.
DR   PDBsum; 4HXK; -.
DR   PDBsum; 4HXL; -.
DR   PDBsum; 4HXM; -.
DR   PDBsum; 4HXN; -.
DR   PDBsum; 4HXO; -.
DR   PDBsum; 4HXP; -.
DR   PDBsum; 4HXR; -.
DR   PDBsum; 4HXS; -.
DR   PDBsum; 4IOO; -.
DR   PDBsum; 4IOQ; -.
DR   PDBsum; 4IOR; -.
DR   PDBsum; 4J0R; -.
DR   PDBsum; 4J0S; -.
DR   PDBsum; 4J3I; -.
DR   PDBsum; 4KV1; -.
DR   PDBsum; 4KV4; -.
DR   PDBsum; 4LR6; -.
DR   PDBsum; 4LRG; -.
DR   PDBsum; 4LYI; -.
DR   PDBsum; 4LYS; -.
DR   PDBsum; 4LYW; -.
DR   PDBsum; 4LZR; -.
DR   PDBsum; 4LZS; -.
DR   PDBsum; 4MEN; -.
DR   PDBsum; 4MEO; -.
DR   PDBsum; 4MEP; -.
DR   PDBsum; 4MEQ; -.
DR   PDBsum; 4MR3; -.
DR   PDBsum; 4MR4; -.
DR   PDBsum; 4NQM; -.
DR   PDBsum; 4NR8; -.
DR   PDBsum; 4NUC; -.
DR   PDBsum; 4NUD; -.
DR   PDBsum; 4NUE; -.
DR   PDBsum; 4O70; -.
DR   PDBsum; 4O71; -.
DR   PDBsum; 4O72; -.
DR   PDBsum; 4O74; -.
DR   PDBsum; 4O75; -.
DR   PDBsum; 4O76; -.
DR   PDBsum; 4O77; -.
DR   PDBsum; 4O78; -.
DR   PDBsum; 4O7A; -.
DR   PDBsum; 4O7B; -.
DR   PDBsum; 4O7C; -.
DR   PDBsum; 4O7E; -.
DR   PDBsum; 4O7F; -.
DR   PDBsum; 4OGI; -.
DR   PDBsum; 4OGJ; -.
DR   PDBsum; 4PCE; -.
DR   PDBsum; 4PCI; -.
DR   PDBsum; 4PS5; -.
DR   PDBsum; 4QB3; -.
DR   PDBsum; 4QR3; -.
DR   PDBsum; 4QR4; -.
DR   PDBsum; 4QR5; -.
DR   PDBsum; 4QZS; -.
DR   PDBsum; 4UIX; -.
DR   PDBsum; 4UIY; -.
DR   PDBsum; 4UIZ; -.
DR   PDBsum; 4UYD; -.
DR   PDBsum; 4WHW; -.
DR   PDBsum; 4WIV; -.
DR   PDBsum; 4X2I; -.
DR   PDBsum; 4XY9; -.
DR   PDBsum; 4XYA; -.
DR   PDBsum; 4YH3; -.
DR   PDBsum; 4YH4; -.
DR   PDBsum; 4Z1Q; -.
DR   PDBsum; 4Z1S; -.
DR   PDBsum; 4Z93; -.
DR   PDBsum; 4ZC9; -.
DR   PDBsum; 4ZW1; -.
DR   PDBsum; 5A5S; -.
DR   PDBsum; 5A85; -.
DR   PDBsum; 5ACY; -.
DR   PDBsum; 5AD2; -.
DR   PDBsum; 5AD3; -.
DR   PDBsum; 5BT4; -.
DR   PDBsum; 5CFW; -.
DR   PDBsum; 5COI; -.
DR   PDBsum; 5CP5; -.
DR   PDBsum; 5CPE; -.
DR   PDBsum; 5CQT; -.
DR   PDBsum; 5CRM; -.
DR   PDBsum; 5CRZ; -.
DR   PDBsum; 5CS8; -.
DR   PDBsum; 5CTL; -.
DR   PDBsum; 5CY9; -.
DR   PDBsum; 5D0C; -.
DR   PDBsum; 5D24; -.
DR   PDBsum; 5D25; -.
DR   PDBsum; 5D26; -.
DR   PDBsum; 5D3H; -.
DR   PDBsum; 5D3J; -.
DR   PDBsum; 5D3L; -.
DR   PDBsum; 5D3N; -.
DR   PDBsum; 5D3P; -.
DR   PDBsum; 5D3R; -.
DR   PDBsum; 5D3S; -.
DR   PDBsum; 5D3T; -.
DR   PDBsum; 5DLX; -.
DR   PDBsum; 5DLZ; -.
DR   PDBsum; 5DW2; -.
DR   PDBsum; 5DX4; -.
DR   PDBsum; 5E0R; -.
DR   PDBsum; 5EGU; -.
DR   PDBsum; 5EI4; -.
DR   PDBsum; 5EIS; -.
DR   PDBsum; 5F5Z; -.
DR   PDBsum; 5F60; -.
DR   PDBsum; 5F61; -.
DR   PDBsum; 5F62; -.
DR   PDBsum; 5F63; -.
DR   PDBsum; 5FBX; -.
DR   PDBsum; 5H21; -.
DR   PDBsum; 5HCL; -.
DR   PDBsum; 5HLS; -.
DR   PDBsum; 5HM0; -.
DR   PDBsum; 5HQ5; -.
DR   PDBsum; 5HQ6; -.
DR   PDBsum; 5HQ7; -.
DR   PDBsum; 5I80; -.
DR   PDBsum; 5I88; -.
DR   PDBsum; 5IGK; -.
DR   PDBsum; 5JWM; -.
DR   PDBsum; 5KDH; -.
DR   PDBsum; 5KHM; -.
DR   PDBsum; 5KJ0; -.
DR   PDBsum; 5KU3; -.
DR   PDBsum; 5LJ1; -.
DR   PDBsum; 5LJ2; -.
DR   PDBsum; 5LRQ; -.
DR   PDBsum; 5LUU; -.
DR   PDBsum; 5M39; -.
DR   PDBsum; 5M3A; -.
DR   PDBsum; 5MKZ; -.
DR   PDBsum; 5MLI; -.
DR   PDBsum; 5N2M; -.
DR   PDBsum; 5NNC; -.
DR   PDBsum; 5NND; -.
DR   PDBsum; 5NNE; -.
DR   PDBsum; 5NNF; -.
DR   PDBsum; 5NNG; -.
DR   PDBsum; 5O97; -.
DR   PDBsum; 5OVB; -.
DR   PDBsum; 5OWM; -.
DR   PDBsum; 5OWW; -.
DR   PDBsum; 5S9P; -.
DR   PDBsum; 5S9Q; -.
DR   PDBsum; 5S9R; -.
DR   PDBsum; 5T35; -.
DR   PDBsum; 5TI2; -.
DR   PDBsum; 5TI3; -.
DR   PDBsum; 5TI4; -.
DR   PDBsum; 5TI5; -.
DR   PDBsum; 5TI6; -.
DR   PDBsum; 5TI7; -.
DR   PDBsum; 5U28; -.
DR   PDBsum; 5U2C; -.
DR   PDBsum; 5U2E; -.
DR   PDBsum; 5U2F; -.
DR   PDBsum; 5UEO; -.
DR   PDBsum; 5UEP; -.
DR   PDBsum; 5UEQ; -.
DR   PDBsum; 5UER; -.
DR   PDBsum; 5UES; -.
DR   PDBsum; 5UET; -.
DR   PDBsum; 5UEU; -.
DR   PDBsum; 5UEV; -.
DR   PDBsum; 5UEX; -.
DR   PDBsum; 5UEY; -.
DR   PDBsum; 5UEZ; -.
DR   PDBsum; 5UF0; -.
DR   PDBsum; 5ULA; -.
DR   PDBsum; 5UOO; -.
DR   PDBsum; 5UVS; -.
DR   PDBsum; 5UVT; -.
DR   PDBsum; 5UVU; -.
DR   PDBsum; 5UVV; -.
DR   PDBsum; 5UVW; -.
DR   PDBsum; 5UVX; -.
DR   PDBsum; 5UVY; -.
DR   PDBsum; 5UVZ; -.
DR   PDBsum; 5V67; -.
DR   PDBsum; 5VBO; -.
DR   PDBsum; 5VBP; -.
DR   PDBsum; 5VOM; -.
DR   PDBsum; 5VZS; -.
DR   PDBsum; 5W55; -.
DR   PDBsum; 5WA5; -.
DR   PDBsum; 5WMA; -.
DR   PDBsum; 5WMD; -.
DR   PDBsum; 5WMG; -.
DR   PDBsum; 5WUU; -.
DR   PDBsum; 5XHY; -.
DR   PDBsum; 5XI2; -.
DR   PDBsum; 5XI3; -.
DR   PDBsum; 5XI4; -.
DR   PDBsum; 5Y1Y; -.
DR   PDBsum; 5Y8C; -.
DR   PDBsum; 5Y8W; -.
DR   PDBsum; 5Y8Y; -.
DR   PDBsum; 5Y8Z; -.
DR   PDBsum; 5Y93; -.
DR   PDBsum; 5Y94; -.
DR   PDBsum; 5YOU; -.
DR   PDBsum; 5YOV; -.
DR   PDBsum; 5YQX; -.
DR   PDBsum; 5Z1R; -.
DR   PDBsum; 5Z1S; -.
DR   PDBsum; 5Z1T; -.
DR   PDBsum; 5Z5T; -.
DR   PDBsum; 5Z5U; -.
DR   PDBsum; 5Z5V; -.
DR   PDBsum; 5Z8G; -.
DR   PDBsum; 5Z8R; -.
DR   PDBsum; 5Z8Z; -.
DR   PDBsum; 5Z90; -.
DR   PDBsum; 5Z9C; -.
DR   PDBsum; 5Z9K; -.
DR   PDBsum; 6AFR; -.
DR   PDBsum; 6AJV; -.
DR   PDBsum; 6AJW; -.
DR   PDBsum; 6AJX; -.
DR   PDBsum; 6AJY; -.
DR   PDBsum; 6AJZ; -.
DR   PDBsum; 6BN7; -.
DR   PDBsum; 6BN8; -.
DR   PDBsum; 6BN9; -.
DR   PDBsum; 6BNB; -.
DR   PDBsum; 6BNH; -.
DR   PDBsum; 6BOY; -.
DR   PDBsum; 6C7Q; -.
DR   PDBsum; 6C7R; -.
DR   PDBsum; 6CD4; -.
DR   PDBsum; 6CD5; -.
DR   PDBsum; 6CIS; -.
DR   PDBsum; 6CIY; -.
DR   PDBsum; 6CJ1; -.
DR   PDBsum; 6CJ2; -.
DR   PDBsum; 6CKR; -.
DR   PDBsum; 6CKS; -.
DR   PDBsum; 6CZU; -.
DR   PDBsum; 6CZV; -.
DR   PDBsum; 6DJC; -.
DR   PDBsum; 6DL2; -.
DR   PDBsum; 6DMJ; -.
DR   PDBsum; 6DML; -.
DR   PDBsum; 6DNE; -.
DR   PDBsum; 6DUV; -.
DR   PDBsum; 6E4A; -.
DR   PDBsum; 6FFD; -.
DR   PDBsum; 6FNX; -.
DR   PDBsum; 6FO5; -.
DR   PDBsum; 6FSY; -.
DR   PDBsum; 6FT3; -.
DR   PDBsum; 6FT4; -.
DR   PDBsum; 6G0D; -.
DR   PDBsum; 6G0E; -.
DR   PDBsum; 6G0F; -.
DR   PDBsum; 6G0G; -.
DR   PDBsum; 6G0H; -.
DR   PDBsum; 6G0O; -.
DR   PDBsum; 6G0P; -.
DR   PDBsum; 6G0Q; -.
DR   PDBsum; 6G0R; -.
DR   PDBsum; 6G0S; -.
DR   PDBsum; 6HDQ; -.
DR   PDBsum; 6HOV; -.
DR   PDBsum; 6I7X; -.
DR   PDBsum; 6I7Y; -.
DR   PDBsum; 6IN1; -.
DR   PDBsum; 6JI3; -.
DR   PDBsum; 6JI4; -.
DR   PDBsum; 6JI5; -.
DR   PDBsum; 6JJ3; -.
DR   PDBsum; 6JJ5; -.
DR   PDBsum; 6JJ6; -.
DR   PDBsum; 6JJB; -.
DR   PDBsum; 6KEC; -.
DR   PDBsum; 6KED; -.
DR   PDBsum; 6KEE; -.
DR   PDBsum; 6KEF; -.
DR   PDBsum; 6KEG; -.
DR   PDBsum; 6KEH; -.
DR   PDBsum; 6KEI; -.
DR   PDBsum; 6KEJ; -.
DR   PDBsum; 6KEK; -.
DR   PDBsum; 6KO2; -.
DR   PDBsum; 6LG4; -.
DR   PDBsum; 6LG5; -.
DR   PDBsum; 6LG6; -.
DR   PDBsum; 6LG7; -.
DR   PDBsum; 6LG8; -.
DR   PDBsum; 6LG9; -.
DR   PDBsum; 6LIH; -.
DR   PDBsum; 6LIM; -.
DR   PDBsum; 6MAU; -.
DR   PDBsum; 6MH1; -.
DR   PDBsum; 6MH7; -.
DR   PDBsum; 6MNL; -.
DR   PDBsum; 6P05; -.
DR   PDBsum; 6PRT; -.
DR   PDBsum; 6PS9; -.
DR   PDBsum; 6PSB; -.
DR   PDBsum; 6Q3Y; -.
DR   PDBsum; 6Q3Z; -.
DR   PDBsum; 6RWJ; -.
DR   PDBsum; 6S25; -.
DR   PDBsum; 6S4B; -.
DR   PDBsum; 6S6K; -.
DR   PDBsum; 6SA2; -.
DR   PDBsum; 6SA3; -.
DR   PDBsum; 6SAH; -.
DR   PDBsum; 6SAJ; -.
DR   PDBsum; 6SB8; -.
DR   PDBsum; 6SE4; -.
DR   PDBsum; 6SIS; -.
DR   PDBsum; 6SWN; -.
DR   PDBsum; 6SWQ; -.
DR   PDBsum; 6TPX; -.
DR   PDBsum; 6TPY; -.
DR   PDBsum; 6TPZ; -.
DR   PDBsum; 6U0D; -.
DR   PDBsum; 6U6K; -.
DR   PDBsum; 6U6L; -.
DR   PDBsum; 6U72; -.
DR   PDBsum; 6U74; -.
DR   PDBsum; 6U8G; -.
DR   PDBsum; 6U8I; -.
DR   PDBsum; 6U8M; -.
DR   PDBsum; 6ULS; -.
DR   PDBsum; 6ULV; -.
DR   PDBsum; 6UVJ; -.
DR   PDBsum; 6UVM; -.
DR   PDBsum; 6UWU; -.
DR   PDBsum; 6UWX; -.
DR   PDBsum; 6V0U; -.
DR   PDBsum; 6V1K; -.
DR   PDBsum; 6V1L; -.
DR   PDBsum; 6V1U; -.
DR   PDBsum; 6VIW; -.
DR   PDBsum; 6VIX; -.
DR   PDBsum; 6VIZ; -.
DR   PDBsum; 6VUB; -.
DR   PDBsum; 6VUC; -.
DR   PDBsum; 6VUF; -.
DR   PDBsum; 6VUJ; -.
DR   PDBsum; 6WGX; -.
DR   PDBsum; 6WVX; -.
DR   PDBsum; 6WW8; -.
DR   PDBsum; 6X7B; -.
DR   PDBsum; 6X7C; -.
DR   PDBsum; 6X7D; -.
DR   PDBsum; 6XUZ; -.
DR   PDBsum; 6XV3; -.
DR   PDBsum; 6XV7; -.
DR   PDBsum; 6XVC; -.
DR   PDBsum; 6YIN; -.
DR   PDBsum; 6YQN; -.
DR   PDBsum; 6YQO; -.
DR   PDBsum; 6YQP; -.
DR   PDBsum; 6YQZ; -.
DR   PDBsum; 6Z7G; -.
DR   PDBsum; 6Z7L; -.
DR   PDBsum; 6Z7M; -.
DR   PDBsum; 6ZB3; -.
DR   PDBsum; 6ZCI; -.
DR   PDBsum; 6ZED; -.
DR   PDBsum; 6ZEL; -.
DR   PDBsum; 6ZF9; -.
DR   PDBsum; 7A9U; -.
DR   PDBsum; 7AJN; -.
DR   PDBsum; 7AQT; -.
DR   PDBsum; 7AXR; -.
DR   PDBsum; 7C2Z; -.
DR   PDBsum; 7C6P; -.
DR   PDBsum; 7DHS; -.
DR   PDBsum; 7EHW; -.
DR   PDBsum; 7EHY; -.
DR   PDBsum; 7EIG; -.
DR   PDBsum; 7EIK; -.
DR   PDBsum; 7EIL; -.
DR   PDBsum; 7JKW; -.
DR   PDBsum; 7JKX; -.
DR   PDBsum; 7JKY; -.
DR   PDBsum; 7JKZ; -.
DR   PDBsum; 7K6G; -.
DR   PDBsum; 7K6H; -.
DR   PDBsum; 7KHH; -.
DR   PDBsum; 7KHL; -.
DR   PDBsum; 7KO0; -.
DR   PDBsum; 7L9M; -.
DR   PDBsum; 7LA9; -.
DR   PDBsum; 7M16; -.
DR   PDBsum; 7MCE; -.
DR   PDBsum; 7MCF; -.
DR   PDBsum; 7MLQ; -.
DR   PDBsum; 7MLR; -.
DR   PDBsum; 7MLS; -.
DR   PDBsum; 7O18; -.
DR   PDBsum; 7OEO; -.
DR   PDBsum; 7P6V; -.
DR   PDBsum; 7P6W; -.
DR   PDBsum; 7P6Y; -.
DR   PDBsum; 7R9C; -.
DR   PDBsum; 7REK; -.
DR   PDBsum; 7REL; -.
DR   PDBsum; 7REM; -.
DR   PDBsum; 7RXR; -.
DR   PDBsum; 7RXS; -.
DR   PDBsum; 7RXT; -.
DR   AlphaFoldDB; O60885; -.
DR   BMRB; O60885; -.
DR   SASBDB; O60885; -.
DR   SMR; O60885; -.
DR   BioGRID; 117036; 1534.
DR   CORUM; O60885; -.
DR   DIP; DIP-39776N; -.
DR   IntAct; O60885; 64.
DR   MINT; O60885; -.
DR   STRING; 9606.ENSP00000263377; -.
DR   BindingDB; O60885; -.
DR   ChEMBL; CHEMBL1163125; -.
DR   DrugCentral; O60885; -.
DR   GuidetoPHARMACOLOGY; 1945; -.
DR   GlyGen; O60885; 8 sites, 2 O-linked glycans (8 sites).
DR   iPTMnet; O60885; -.
DR   MetOSite; O60885; -.
DR   PhosphoSitePlus; O60885; -.
DR   SwissPalm; O60885; -.
DR   BioMuta; BRD4; -.
DR   EPD; O60885; -.
DR   jPOST; O60885; -.
DR   MassIVE; O60885; -.
DR   MaxQB; O60885; -.
DR   PaxDb; O60885; -.
DR   PeptideAtlas; O60885; -.
DR   PRIDE; O60885; -.
DR   ProteomicsDB; 49651; -. [O60885-1]
DR   ProteomicsDB; 49652; -. [O60885-2]
DR   ProteomicsDB; 62139; -.
DR   ABCD; O60885; 4 sequenced antibodies.
DR   Antibodypedia; 13956; 448 antibodies from 37 providers.
DR   DNASU; 23476; -.
DR   Ensembl; ENST00000263377.6; ENSP00000263377.1; ENSG00000141867.19. [O60885-1]
DR   Ensembl; ENST00000360016.9; ENSP00000353112.4; ENSG00000141867.19. [O60885-3]
DR   Ensembl; ENST00000371835.8; ENSP00000360901.3; ENSG00000141867.19. [O60885-2]
DR   Ensembl; ENST00000679869.1; ENSP00000506350.1; ENSG00000141867.19. [O60885-1]
DR   GeneID; 23476; -.
DR   KEGG; hsa:23476; -.
DR   MANE-Select; ENST00000679869.1; ENSP00000506350.1; NM_001379291.1; NP_001366220.1.
DR   UCSC; uc002nar.4; human. [O60885-1]
DR   CTD; 23476; -.
DR   DisGeNET; 23476; -.
DR   GeneCards; BRD4; -.
DR   GeneReviews; BRD4; -.
DR   HGNC; HGNC:13575; BRD4.
DR   HPA; ENSG00000141867; Low tissue specificity.
DR   MalaCards; BRD4; -.
DR   MIM; 608749; gene.
DR   neXtProt; NX_O60885; -.
DR   OpenTargets; ENSG00000141867; -.
DR   Orphanet; 199; Cornelia de Lange syndrome.
DR   Orphanet; 443167; NUT midline carcinoma.
DR   PharmGKB; PA25416; -.
DR   VEuPathDB; HostDB:ENSG00000141867; -.
DR   eggNOG; KOG1474; Eukaryota.
DR   GeneTree; ENSGT00940000154549; -.
DR   HOGENOM; CLU_001499_0_3_1; -.
DR   InParanoid; O60885; -.
DR   OMA; YKIIRSP; -.
DR   OrthoDB; 619848at2759; -.
DR   PhylomeDB; O60885; -.
DR   TreeFam; TF317345; -.
DR   PathwayCommons; O60885; -.
DR   Reactome; R-HSA-9679191; Potential therapeutics for SARS.
DR   SignaLink; O60885; -.
DR   SIGNOR; O60885; -.
DR   BioGRID-ORCS; 23476; 698 hits in 1128 CRISPR screens.
DR   ChiTaRS; BRD4; human.
DR   EvolutionaryTrace; O60885; -.
DR   GeneWiki; BRD4; -.
DR   GenomeRNAi; 23476; -.
DR   Pharos; O60885; Tchem.
DR   PRO; PR:O60885; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; O60885; protein.
DR   Bgee; ENSG00000141867; Expressed in buccal mucosa cell and 211 other tissues.
DR   ExpressionAtlas; O60885; baseline and differential.
DR   Genevisible; O60885; HS.
DR   GO; GO:0000785; C:chromatin; IBA:GO_Central.
DR   GO; GO:0005694; C:chromosome; IDA:UniProtKB.
DR   GO; GO:0000794; C:condensed nuclear chromosome; IDA:MGI.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0140566; F:histone reader activity; IDA:GO_Central.
DR   GO; GO:0070577; F:lysine-acetylated histone binding; IDA:UniProtKB.
DR   GO; GO:0106140; F:P-TEFb complex binding; IDA:FlyBase.
DR   GO; GO:0002039; F:p53 binding; IDA:UniProtKB.
DR   GO; GO:0099122; F:RNA polymerase II C-terminal domain binding; IDA:MGI.
DR   GO; GO:0008353; F:RNA polymerase II CTD heptapeptide repeat kinase activity; IMP:MGI.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IMP:UniProtKB.
DR   GO; GO:0003712; F:transcription coregulator activity; IMP:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB.
DR   GO; GO:0006338; P:chromatin remodeling; IDA:UniProtKB.
DR   GO; GO:0043922; P:negative regulation by host of viral transcription; IDA:FlyBase.
DR   GO; GO:2000002; P:negative regulation of DNA damage checkpoint; IMP:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IMP:UniProtKB.
DR   GO; GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IMP:MGI.
DR   GO; GO:2001255; P:positive regulation of histone H3-K36 trimethylation; IMP:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0032968; P:positive regulation of transcription elongation by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IBA:GO_Central.
DR   GO; GO:0050727; P:regulation of inflammatory response; IDA:UniProtKB.
DR   GO; GO:0000083; P:regulation of transcription involved in G1/S transition of mitotic cell cycle; IMP:MGI.
DR   CDD; cd05497; Bromo_Brdt_I_like; 1.
DR   CDD; cd05498; Bromo_Brdt_II_like; 1.
DR   DisProt; DP01898; -.
DR   Gene3D; 1.20.1270.220; -; 1.
DR   Gene3D; 1.20.920.10; -; 2.
DR   IDEAL; IID00111; -.
DR   InterPro; IPR031354; BRD4_CDT.
DR   InterPro; IPR043508; Bromo_Brdt_I.
DR   InterPro; IPR043509; Bromo_Brdt_II.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR018359; Bromodomain_CS.
DR   InterPro; IPR027353; NET_dom.
DR   InterPro; IPR038336; NET_sf.
DR   Pfam; PF17035; BET; 1.
DR   Pfam; PF17105; BRD4_CDT; 1.
DR   Pfam; PF00439; Bromodomain; 2.
DR   PRINTS; PR00503; BROMODOMAIN.
DR   SMART; SM00297; BROMO; 2.
DR   SUPFAM; SSF47370; SSF47370; 2.
DR   PROSITE; PS00633; BROMODOMAIN_1; 1.
DR   PROSITE; PS50014; BROMODOMAIN_2; 2.
DR   PROSITE; PS51525; NET; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Bromodomain;
KW   Chromatin regulator; Chromosomal rearrangement; Chromosome; DNA damage;
KW   Host-virus interaction; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..1362
FT                   /note="Bromodomain-containing protein 4"
FT                   /id="PRO_0000211183"
FT   DOMAIN          75..147
FT                   /note="Bromo 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00035"
FT   DOMAIN          368..440
FT                   /note="Bromo 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00035"
FT   DOMAIN          600..682
FT                   /note="NET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00857"
FT   REGION          1..58
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          174..229
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          242..352
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          463..615
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          484..503
FT                   /note="NPS region"
FT   REGION          524..579
FT                   /note="BID region"
FT   REGION          674..1100
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1047..1362
FT                   /note="C-terminal (CTD) region"
FT   REGION          1116..1339
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        20..39
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        191..207
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        208..224
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        243..274
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        316..340
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        482..496
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        503..517
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        549..573
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        597..615
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        694..708
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        729..745
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        751..788
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        830..847
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        926..941
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        947..999
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1012..1036
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1068..1094
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1176..1192
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1204..1224
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1225..1287
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1288..1323
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1324..1339
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            140
FT                   /note="Acetylated histone binding"
FT                   /evidence="ECO:0000269|PubMed:22464331"
FT   SITE            433
FT                   /note="Acetylated histone binding"
FT                   /evidence="ECO:0000269|PubMed:22464331"
FT   SITE            719..720
FT                   /note="Breakpoint for translocation to form BDR4-NUTM1
FT                   fusion protein"
FT   MOD_RES         470
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         484
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:23317504"
FT   MOD_RES         488
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:23317504"
FT   MOD_RES         492
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:23317504"
FT   MOD_RES         494
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:23317504"
FT   MOD_RES         498
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:23317504"
FT   MOD_RES         499
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:23317504"
FT   MOD_RES         503
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:23317504"
FT   MOD_RES         601
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         1111
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         1117
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         1126
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1201
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1204
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   CROSSLNK        99
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        585
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        645
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        694
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        1050
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        1111
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   CROSSLNK        1111
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:25114211,
FT                   ECO:0007744|PubMed:25218447, ECO:0007744|PubMed:25755297,
FT                   ECO:0007744|PubMed:25772364, ECO:0007744|PubMed:28112733"
FT   CROSSLNK        1197
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         720..1362
FT                   /note="EMAPKSKKKGHPGREQKKHHHHHHQQMQQAPAPVPQQPPPPPQQPPPPPPPQ
FT                   QQQQPPPPPPPPSMPQQAAPAMKSSPPPFIATQVPVLEPQLPGSVFDPIGHFTQPILHL
FT                   PQPELPPHLPQPPEHSTPPHLNQHAVVSPPALHNALPQQPSRPSNRAAALPPKPARPPA
FT                   VSPALTQTPLLPQPPMAQPPQVLLEDEEPPAPPLTSMQMQLYLQQLQKVQPPTPLLPSV
FT                   KVQSQPPPPLPPPPHPSVQQQLQQQPPPPPPPQPQPPPQQQHQPPPRPVHLQPMQFSTH
FT                   IQQPPPPQGQQPPHPPPGQQPPPPQPAKPQQVIQHHHSPRHHKSDPYSTGHLREAPSPL
FT                   MIHSPQMSQFQSLTHQSPPQQNVQPKKQELRAASVVQPQPLVVVKEEKIHSPIIRSEPF
FT                   SPSLRPEPPKHPESIKAPVHLPQRPEMKPVDVGRPVIRPPEQNAPPPGAPDKDKQKQEP
FT                   KTPVAPKKDLKIKNMGSWASLVQKHPTTPSSTAKSSSDSFEQFRRAAREKEEREKALKA
FT                   QAEHAEKEKERLRQERMRSREDEDALEQARRAHEEARRRQEQQQQQRQEQQQQQQQQAA
FT                   AVAAAATPQAQSSQPQSMLDQQRELARKREQERRRREAMAATIDMNFQSDLLSIFEENL
FT                   F -> AFCTSGDFVSPGPSPYHSHVQCGRFREMLRWFLVDVEQTAAGQPHRQSAAGPAI
FT                   TWAPAIAYPSPECARCCVGCS (in isoform B)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_047671"
FT   VAR_SEQ         720..722
FT                   /note="EMA -> GPA (in isoform C)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_010902"
FT   VAR_SEQ         723..1362
FT                   /note="Missing (in isoform C)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_010903"
FT   VARIANT         37
FT                   /note="P -> S (in dbSNP:rs35177876)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041919"
FT   VARIANT         371
FT                   /note="A -> G (in dbSNP:rs55805532)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041920"
FT   VARIANT         563
FT                   /note="S -> N (in dbSNP:rs55970906)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041921"
FT   VARIANT         598
FT                   /note="T -> S (in dbSNP:rs34362023)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041922"
FT   VARIANT         669
FT                   /note="R -> H (in dbSNP:rs35824241)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041923"
FT   VARIANT         1097
FT                   /note="R -> H (in dbSNP:rs35676845)"
FT                   /id="VAR_048427"
FT   MUTAGEN         140
FT                   /note="N->A: Abolishes binding to acetylated histones."
FT                   /evidence="ECO:0000269|PubMed:22464331,
FT                   ECO:0000269|PubMed:23728299"
FT   MUTAGEN         433
FT                   /note="N->A: Abolishes binding to acetylated histones."
FT                   /evidence="ECO:0000269|PubMed:22464331"
FT   MUTAGEN         492..494
FT                   /note="SSS->ASA: Impaired phosphorylation by CK2 and
FT                   binding to acetylated histones."
FT                   /evidence="ECO:0000269|PubMed:23317504"
FT   MUTAGEN         498..500
FT                   /note="SST->AAA: Impaired phosphorylation by CK2 and
FT                   binding to acetylated histones."
FT                   /evidence="ECO:0000269|PubMed:23317504"
FT   MUTAGEN         503
FT                   /note="S->A: Impaired phosphorylation by CK2 and binding to
FT                   acetylated histones."
FT                   /evidence="ECO:0000269|PubMed:23317504"
FT   MUTAGEN         651..653
FT                   /note="EIE->AIA: Decreases interaction with JMJD6 and
FT                   NSD3.No effect on interaction with histone 4 acetylated."
FT                   /evidence="ECO:0000269|PubMed:29176719"
FT   STRAND          53..55
FT                   /evidence="ECO:0007829|PDB:4WHW"
FT   STRAND          57..60
FT                   /evidence="ECO:0007829|PDB:6X7B"
FT   HELIX           61..68
FT                   /evidence="ECO:0007829|PDB:4QB3"
FT   HELIX           70..75
FT                   /evidence="ECO:0007829|PDB:4QB3"
FT   HELIX           81..83
FT                   /evidence="ECO:0007829|PDB:4QB3"
FT   STRAND          84..86
FT                   /evidence="ECO:0007829|PDB:5Z1S"
FT   TURN            89..93
FT                   /evidence="ECO:0007829|PDB:4QB3"
FT   HELIX           97..100
FT                   /evidence="ECO:0007829|PDB:4QB3"
FT   HELIX           107..115
FT                   /evidence="ECO:0007829|PDB:4QB3"
FT   STRAND          119..121
FT                   /evidence="ECO:0007829|PDB:6X7D"
FT   HELIX           122..139
FT                   /evidence="ECO:0007829|PDB:4QB3"
FT   HELIX           145..161
FT                   /evidence="ECO:0007829|PDB:4QB3"
FT   STRAND          170..174
FT                   /evidence="ECO:0007829|PDB:6X7B"
FT   STRAND          342..346
FT                   /evidence="ECO:0007829|PDB:2LSP"
FT   HELIX           350..364
FT                   /evidence="ECO:0007829|PDB:4Z93"
FT   HELIX           367..369
FT                   /evidence="ECO:0007829|PDB:4Z93"
FT   HELIX           370..373
FT                   /evidence="ECO:0007829|PDB:4Z93"
FT   HELIX           374..376
FT                   /evidence="ECO:0007829|PDB:4Z93"
FT   HELIX           382..385
FT                   /evidence="ECO:0007829|PDB:4Z93"
FT   HELIX           390..393
FT                   /evidence="ECO:0007829|PDB:4Z93"
FT   HELIX           400..408
FT                   /evidence="ECO:0007829|PDB:4Z93"
FT   STRAND          412..414
FT                   /evidence="ECO:0007829|PDB:2MJV"
FT   HELIX           415..432
FT                   /evidence="ECO:0007829|PDB:4Z93"
FT   STRAND          435..437
FT                   /evidence="ECO:0007829|PDB:2I8N"
FT   HELIX           438..454
FT                   /evidence="ECO:0007829|PDB:4Z93"
FT   HELIX           602..605
FT                   /evidence="ECO:0007829|PDB:2NCZ"
FT   HELIX           612..624
FT                   /evidence="ECO:0007829|PDB:2N3K"
FT   HELIX           627..640
FT                   /evidence="ECO:0007829|PDB:2N3K"
FT   HELIX           642..644
FT                   /evidence="ECO:0007829|PDB:2NCZ"
FT   STRAND          651..655
FT                   /evidence="ECO:0007829|PDB:2N3K"
FT   TURN            656..658
FT                   /evidence="ECO:0007829|PDB:2N3K"
FT   HELIX           661..675
FT                   /evidence="ECO:0007829|PDB:2N3K"
FT   TURN            676..678
FT                   /evidence="ECO:0007829|PDB:6BNH"
FT   HELIX           1345..1354
FT                   /evidence="ECO:0007829|PDB:2NNU"
FT   TURN            1355..1357
FT                   /evidence="ECO:0007829|PDB:2NNU"
SQ   SEQUENCE   1362 AA;  152219 MW;  D52EFE1CF9960907 CRC64;
     MSAESGPGTR LRNLPVMGDG LETSQMSTTQ AQAQPQPANA ASTNPPPPET SNPNKPKRQT
     NQLQYLLRVV LKTLWKHQFA WPFQQPVDAV KLNLPDYYKI IKTPMDMGTI KKRLENNYYW
     NAQECIQDFN TMFTNCYIYN KPGDDIVLMA EALEKLFLQK INELPTEETE IMIVQAKGRG
     RGRKETGTAK PGVSTVPNTT QASTPPQTQT PQPNPPPVQA TPHPFPAVTP DLIVQTPVMT
     VVPPQPLQTP PPVPPQPQPP PAPAPQPVQS HPPIIAATPQ PVKTKKGVKR KADTTTPTTI
     DPIHEPPSLP PEPKTTKLGQ RRESSRPVKP PKKDVPDSQQ HPAPEKSSKV SEQLKCCSGI
     LKEMFAKKHA AYAWPFYKPV DVEALGLHDY CDIIKHPMDM STIKSKLEAR EYRDAQEFGA
     DVRLMFSNCY KYNPPDHEVV AMARKLQDVF EMRFAKMPDE PEEPVVAVSS PAVPPPTKVV
     APPSSSDSSS DSSSDSDSST DDSEEERAQR LAELQEQLKA VHEQLAALSQ PQQNKPKKKE
     KDKKEKKKEK HKRKEEVEEN KKSKAKEPPP KKTKKNNSSN SNVSKKEPAP MKSKPPPTYE
     SEEEDKCKPM SYEEKRQLSL DINKLPGEKL GRVVHIIQSR EPSLKNSNPD EIEIDFETLK
     PSTLRELERY VTSCLRKKRK PQAEKVDVIA GSSKMKGFSS SESESSSESS SSDSEDSETE
     MAPKSKKKGH PGREQKKHHH HHHQQMQQAP APVPQQPPPP PQQPPPPPPP QQQQQPPPPP
     PPPSMPQQAA PAMKSSPPPF IATQVPVLEP QLPGSVFDPI GHFTQPILHL PQPELPPHLP
     QPPEHSTPPH LNQHAVVSPP ALHNALPQQP SRPSNRAAAL PPKPARPPAV SPALTQTPLL
     PQPPMAQPPQ VLLEDEEPPA PPLTSMQMQL YLQQLQKVQP PTPLLPSVKV QSQPPPPLPP
     PPHPSVQQQL QQQPPPPPPP QPQPPPQQQH QPPPRPVHLQ PMQFSTHIQQ PPPPQGQQPP
     HPPPGQQPPP PQPAKPQQVI QHHHSPRHHK SDPYSTGHLR EAPSPLMIHS PQMSQFQSLT
     HQSPPQQNVQ PKKQELRAAS VVQPQPLVVV KEEKIHSPII RSEPFSPSLR PEPPKHPESI
     KAPVHLPQRP EMKPVDVGRP VIRPPEQNAP PPGAPDKDKQ KQEPKTPVAP KKDLKIKNMG
     SWASLVQKHP TTPSSTAKSS SDSFEQFRRA AREKEEREKA LKAQAEHAEK EKERLRQERM
     RSREDEDALE QARRAHEEAR RRQEQQQQQR QEQQQQQQQQ AAAVAAAATP QAQSSQPQSM
     LDQQRELARK REQERRRREA MAATIDMNFQ SDLLSIFEEN LF
//
